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Abstract
Background and Aims: "Mitochondrial theory of ageing" is an established theory
which states that there is a correlation between Maximum Life Span (MLSP) of an
organism and its mitochondrial free radical production. Here we are trying to extend
this theory to determine if there is a correlation between stability of Complex I proteins
of the electron transport chain (ETC) and MLSP. Through this we want to establish
if there are Complex I proteins which might be involved in ageing of organisms. We
selected Complex I because it is the first complex of the ETC and ETC is located in
the mitochondria (free radical damage is the maximum in mitochondria as per the free
radical theory of ageing).
Methods: Downloaded orthologs for all the 45 proteins of Complex I and used I-mutant
program to find the stability of proteins after mutation. We applied all possible mutations
at each site of the protein and then applied various methods to establish the change in
protein stability which tells us whether the protein becomes more stable or less stable
after the mutations. We then used the stability value and MLSP to find if there is a
correlation (Spearman’s ρ) between protein stability and MLSP and for the significance
of the result, we find p-value corresponding to each ρ.
Results: Out of the 45 proteins, we got 19 proteins which had a significant correlation
between MLSP and protein stability. Moreover some of these proteins were found to be
involved in catalytic activity of the complex and some of the proteins with a significant
MLSP and protein stability correlation were found to be encoded by the mitochondria.
Conclusion: Since there is a significant correlation between protein stability and MLSP
for 19 out of 45 proteins, we can say that these proteins of Complex I might have some
role in the process of ageing of organisms.
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1. Introduction
The stability of a protein depends on the change in free energy between a folded and
unfolded protein which is also called the change in Gibbs free energy. A negative value
of Gibbs free energy ∆G indicates a stable protein. When a protein is formed, it is in an
unfolded state. From that state, it changes to a folded state (also called the native state
of a protein) (Baldwin, 2007). The three dimensional structure of a protein which is also
called tertiary structure is of prime importance because it determines the functionality
of the protein (Petsko and Ringe, 2004). Tertiary structure is the way the whole protein
folds to make a functional protein. It is the free energy change from the initial unfolded
protein to this folded state protein which determines the stability of the protein (∆G)
(Creighton, 1990).
In many cases if a single amino acid in the protein is substituted by another residue, it
makes the protein unstable (Capriotti et al., 2005; Cheng et al., 2006). In that case, the
∆G of the mutated protein is more than the ∆G of the wild type protein. Sometimes a
substitution can even decrease the ∆G value in which case the mutated protein becomes
more stable than the wild type protein. The result of reduced stability can be an unstable
protein or a protein which is unsuitable because of loss of activity. There are many
diseases which are caused by a mutation (which results in an amino acid change in
protein). One such disease is sickle cell anaemia.
In the thesis, we studied electron transport chain Complex I proteins. The electron
transport chain is in the mitochondria and its function is ATP production (Berg JM,
2002a). However as by products the electron transport chain also produces Reactive
Oxygen Species (ROS) (Finkel and Holbrook, 2000). These are harmful for proteins, DNA
and lipids. The cells have mechanisms to counter the effect of ROS however they are still
able to cause some oxidative damage (Berg JM, 2002a). The electron transport chain is
composed of four complexes (not including the ATP synthase which is sometimes called
the fifth complex) (Berg JM, 2002a). Complex I is the first complex in the respiratory
chain and is shaped like an L (Carroll et al., 2006; Yamaguchi et al., 1998; Grigorieff,
1999). It is composed of 45 proteins out of which 7 are encoded by mitochondrial DNA
and 38 are encoded by nuclear DNA (Carroll et al., 2006).
There have been several studies which study the effect of oxidative damage to mitochon-
drial DNA and Maximum Life Span (MLSP) of species or the relationship between ROS
produced by mitochondrial DNA and MLSP of organisms (Barja, 1998; Ku et al., 1993;
Ku and Sohal, 1993). The mitochondrial DNA is present in the mitochondria and thus
it is closely affected by ROS produced by the electron transport chain. By these studies,
it was discovered that there is a negative correlation between damage to mitochondrial
DNA and MLSP of various species (the same effect was not discovered with damage to
1
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nuclear DNA).
In our study we will try to find out if there is a relationship between stability of electron
transport chain Complex I proteins and MLSP of species. No such study has been made
till now.
2
2. Review of Literature
The genes we have for our analysis are mitochondrial genes. More specifically they are
genes which form the sub-components of NADH: ubiquinone oxidoreductase complex of
the respiratory chain (Complex I) enzyme (also called NADH dehydrogenase (ubiquinone)
in humans. In the eukaryotes, it is located in the inner mitochondrial membrane. This
complex is composed of mitochondrial genes and nuclear genes.
2.1. Mitochondria and its Structure
Mitochondria have their own DNA. Each mitochondria contains multiple copies of mito-
chondrial genome. A mammalian mitochondrial genome consists of approximately 16.5
kilobases of circular genome (Hebert et al., 2010). Though mitochondria has its own DNA,
a number of proteins used in the mitochondria are produced by the nuclear genome and
are then transported to the mitochondria. NADH: ubiquinone oxidoreductase complex
(complex I) which we will see in more detail is one such complex which is composed by
proteins made from mitochondrial genome as well as nuclear genome.
Mitochondria are known as the powerhouse of the cell because they generate energy for
the cell to use. They are rod shaped organelles and convert oxygen and nutrients to
ATP. This process is called aerobic respiration. It produces 15 times more energy than
anaerobic respiration. Mitochondria has two membranes called the inner membrane and
outer membrane. The space between these two membranes is called the inter-membrane
space. The inner membrane has folds which are called cristae and the space within the
inner membrane is called matrix (Cooper, 2000). To understand the working of NADH:
ubiquinone oxidoreductase complex and the position of our genes, we should look at the
structure of a mitochondria first. It has a structure as given by the figure: 2.1.
2.2. Complex I
As we have seen above, Complex I is a complex which is composed of proteins made
from nuclear genome as well as mitochondrial genome. There are basically four enzyme
complexes which make up the respiratory chain. Out of these four, three are involved
in pumping protons across the inter-membrane space. They are: NADH dehydrogenase
or complex I, cytochrome reductase or complex III and cytochrome oxidase or complex
IV (Weiss et al., 1992). Of these three enzymes, complex I is the first enzyme of the
mitochondrial electron transport chain.
3
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Figure 2.1.: The structure of a mitochondria showing the matrix, inner membrane, outer
membrane and inter-membrane space. Source: (Kelvinsong, 2013).
2.2.1. Composition of Complex I
The enzyme has a mass of approximately 1 MDa (Hirst et al., 2003; Carroll et al., 2006;
Murray et al., 2003). Analysis of bovine enzyme shows that it is composed of 45 subunits
(Carroll et al., 2006). Another article listed the total components of Complex I as 46
(Lenaz et al., 2006). However in (Carroll et al., 2006) it has been proved to be a complex
of 45 different proteins, a non-covalently bonded FMN and eight iron-sulphur complexes.
Yet another recent article indicates that NDUFA4 which was initially thought to be a
sub-unit of mammalian Complex I is in fact a sub-unit of Complex IV (Balsa et al.,
2012). Thus making the total number of proteins which are a constituent of mammalian
Complex I to be 44 instead of the previously known 45. In our study however we have
included the NDUFA4 protein. The list of all genes which make up Complex I and their
genomic location is given in table A.3 in appendix. These are the genes whose orthologs
we have analysed for protein stability.
2.2.2. Structure of Complex I
Complex I has an L shape where one arm of L is in the inner mitochondrial membrane
and the other perpendicular arm which is the hydrophilic arm (also called the periph-
eral arm) is in the mitochondrial matrix (Carroll et al., 2006; Yamaguchi et al., 1998;
Grigorieff, 1999). The hydrophilic arm contains the NADH substrate binding site and
flavin mononucleotide (FMN) (Brandt, 2006; Grigorieff, 1999). The hydrophilic arm also
contains iron-sulphur clusters (8 of the 9 Fe-S clusters). 7 iron-sulphur clusters help in
the transport of electrons along the complex (Brandt, 2006). The L shape of Complex I
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is given by the figure: 2.2
2.2.3. "Core" of Complex I
Further analysis of Complex I indicates that out of the 44 subunits, 14 are called the cen-
tral subunits also called the "core" of the complex (Brandt, 2006; Carroll et al., 2006).
Of these 14 sub-units seven subunits are highly hydrophobic whereas the other seven
are not(Brandt, 2006). The hydrophobic prediction is made by certain algorithms which
predict the number of transmembrane helices in the various segments of the protein. The
seven hydrophobic subunits are encoded by the seven mitochondrial genes (ND1-ND6
and ND4L) (Lenaz et al., 2006; Brandt, 2006). The other seven sub-units are encoded
by nuclear genes (in fact except for the 7 proteins encoded by the mitochondrial genes,
rest all the 37 proteins which form the other 37 subunits of the complex are encoded
by nuclear genes). The genes encoding the other 7 proteins are: NDUFS1, NDUFV1,
NDUFS2, NDUFS3, NDUFV2, NDUFS8, NDUFS7 (Brandt, 2006). The "Core" of com-
plex I are also genes with catalytic activity. The genes with catalytic activity are men-
tioned in paper (Benit et al., 2004) and these names were also found from entrez (Ma-
glott et al., 2005). The genes involved in catalytic activity are thus: NDUFS1, NDUFS2,
NDUFS3, NDUFS8, NDUFS7, NDUFV1, NDUFV2, ND1, ND2, ND3, ND4, ND4L, ND5
and ND6.
2.2.4. Sub-complexes in Complex I
Another manner in which Complex I can be roughly segregated is by its 4 sub-complexes
into which it readily separates in the presence of chaotropes (which are agents that in
a water solution can disrupt hydrogen bonds) (Brandt, 2006; Carroll et al., 2006). The
1λ corresponds to the peripheral arm (Carroll et al., 2006) Sub-complex 1α is basically
a combination of 1λ and 8 more sub-units (Hirst et al., 2003). The rest of the complex
arm contains 1β and 1γ. The sub-complexes for Complex I are shown in the figure: 2.2.
2.3. Electron transport chain (also called the
respiratory chain)
Electron transport chain is a series of protein complexes which help in moving electrons
along the chain and in process, pump protons H+ across a membrane. The electron
transport chain in mitochondria consists of four complexes (Alberts B, 1994). They are
NADH dehydrogenase (Complex I), succinate dehydrogenase (Complex II), cytochrome
reductase (Complex III) and cytochrome c oxidase (Complex IV) (Berg JM, 2002b).
2.3.1. Overview of the electron (respiratory) transport chain
In the respiratory chain NADH and H+ supply 2 electrons at Complex I. These electrons
then pass through the complex and in turn pump 4 protons from matrix, across the in-
5
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Figure 2.2.: The L shape of Complex I and the location of the peripheral arm and the
hydrophobic arm. The spheres in N and Q are iron-sulphur clusters. The
image also shows the sub-complexes of Complex I. N and Q (minus the FMN
unit) which form the peripheral arm form 1λ. 1α is 1λ and 8 more sub-units
from PP. The remaining PP and PD is 1γ and 1β respectively. Source: (Dröse
et al., 2011)
ner mitochondrial membrane to the inter-membrane space. Likewise complex III and IV
pump protons across the membrane (4 protons and 2 protons respectively) (Berg JM,
2002b). In complex IV oxygen molecule in turn gets reduced to produce water molecule.
Each NADH thus supplies 2 electrons to the chain which pumps 10 protons across the
membrane and in the last complex (complex IV) one half oxygen molecule produces a
water molecule. (Complex II does not pump any protons across the membrane). In com-
plex II succinate is oxidised to fumarate and in this process two electrons are channelled
into the chain from Complex II. However in this process no protons are pumped across
the membrane like it happens in complex I, III and IV. Water production at Complex IV
(Alberts B, 1994) happens as follows:
1
2
O
2
+ 2 e− + 2 H+ −−→ 2 H2O (2.1)
The electron transport chain is shown by the figure: 2.3
2.3.2. ATP production
Now this proton gradient that is developed helps in the production of ATP from ADP
and phosphate(Pi). For this process ATP synthase enzyme which is also sometimes called
Complex V is used. Due to the proton gradient, protons which are in excess in the inter-
membrane space, cross the inner mitochondrial membrane through the ATP synthase
enzyme. This crossing over causes rotation in the Fo subunit and the γ subunit of ATP
6
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Figure 2.3.: Electron Transport Chain or Respiratory chain. Source: (Fvasconcellos,
2007).
synthase. This movement produces energy for the active sites in the β subunit which
produces ATP (Schultz and Chan, 2001; Alberts B, 1994). This reaction is represented
as follows:
ADP + Pi + H
+ + 4 H+C −−→ ATP + H2O + 4 H+M (2.2)
The M and C subscript are for mitochondrial matrix and cytosol respectively.
2.3.3. Role of Complex I in the Electron transport chain
The role of Complex I in the electron transport chain is that it oxidises NADH and
in that process, 2 electrons are donated to the complex and pass through the complex
(being helped by the iron-sulphur clusters in their transfer to ubiquinone). Ubiquinone
is a freely moving molecule which gets reduced to ubiquinol. In this complete process
Complex I pumps 4 protons across its membrane and the ubiquinol travels via the in-
ner mitochondrial membrane to complex III (bypassing complex II) (Schultz and Chan,
2001).
The equation for the reaction catalysed by Complex I is as follows (Schultz and Chan,
2001; Berg JM, 2002b):
NADH + H+ + CoQ + 4 H+M −−→ NAD+ + CoQH2 + 4 H+C (2.3)
The M and C subscript are for mitochondrial matrix and cytosol respectively.
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2.4. Oxidative Phosphorylation
As we saw above, in the electron transport chain, NADH which is produced in the citric
acid cycle is oxidised to NAD+, succinate is oxidised to fumarate and oxygen is reduced
to water and in turn energy in the form of ATP is produced. This whole metabolic
pathway is an example of oxidative phosphorylation occurring in the Electron transport
chain (ETC) in the mitochondrial membrane.
2.4.1. Reactive oxygen species
Reactive oxygen species (ROS) are reactive molecules which have oxygen. We can also
call them free radicals with oxygen. Free radicals are chemicals with unpaired electrons
in their outer orbit (Turrens, 2003). Free radicals and ROS components are short-lived
and highly reactive (because they are unstable and try to achieve stability by reacting
with other molecules).There can be endogenous and exogenous factors which produce
ROS. Exogenous factors would be smoking, pollution, UV rays and the like. Endogenous
oxygen radical generation occurs in vivo and is caused by redox reactions (Beckman and
Ames, 1998). Among other sites, the electron transport chain is a major site for ROS
production. We are mainly talking about ROS regarding mitochondria because major
intracellular ROS production stems from the mitochondria (Finkel and Holbrook, 2000).
Superoxide anions are produced in Complex I, Complex II and Complex III of the ETC
(Turrens, 2003). They are said to "leak electrons" to oxygen. The list of all ROS from
the electron transport chain are (Turrens, 2003; Finkel and Holbrook, 2000):
• Oxygen (O2)
• Superoxide anion (O–•2 )
• Hydroxyl ion (OH–)
• Hydroxyl radical (OH•)
• Peroxide (O2–2 )
• Hydrogen Peroxide (H2O2)
The equation for superoxide and peroxide production is as follows (Berg JM, 2002b)
O2
e−−−→ O−2
superoxide
e−−−→ O2−2
peroxide
(2.4)
A point worth mentioning here is that the cells by themselves have a good anti-oxidant
defence mechanism (Turrens, 2003; Finkel and Holbrook, 2000; Berg JM, 2002b) and
despite that there is oxidative damage. Oxidative stress is the difference between ROS
production and antioxidant defence (Finkel and Holbrook, 2000). The stress causes mu-
tation in proteins, lipids and DNA. One of the enzymes produced by the cells to counter
the effect of ageing is superoxide dismutase. It calalyzes the conversion of two superoxide
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radicals into an oxygen and hydrogen peroxide(Berg JM, 2002b). The reaction is given
below:
2 O−•2 + 2 H
+ −−⇀↽− O2 + H2O2 (2.5)
2.5. Free radical theory of Ageing
The free radical theory of ageing was first proposed in the year 1956 (Beckman and Ames,
1998). The theory states that ROS play an important role in ageing of organism. Several
experiments support the theory that free radicals play an important role in ageing even
if they might not determine the life span of the organism (Beckman and Ames, 1998).
Free radical theory of ageing gave way to the "rate of living hypothesis".
2.6. Rate of living hypothesis
According to the rate of living hypothesis, there is a negative correlation between metabolic
rate and maximum life span(MLSP) (Beckman and Ames, 1998). The metabolic rate cor-
responds to the consumption of oxygen during a lifetime. However certain discrepancies
were found in this theory. As per (Beckman and Ames, 1998), oxygen consumption of
pigeon, canary, rats and guinea pigs is: 465, 1222, 28 and 48 litre O2/g respectively
and their MLSP is 37, 24, 4 and 8 years respectively. It was proved that MLSP is not
correlated with the rate of consumption of oxygen. Also generation of oxidants is not cor-
related with the metabolic rate (which is oxygen consumption during a lifetime). Several
experiments have confirmed that MLSP is correlated with the capacity of mitochondrial
oxidant generation (Barja, 1998; Ku et al., 1993; Ku and Sohal, 1993).
In (Barja, 1998), they have compared adult male rats (with MLSP=4years) and adult
pigeons (with MLSP 35 years). The O2 consumption of the whole animal at rest, as well
as the O2 consumption of brain, liver and lung mitochondria were higher in the pigeon
than the rat. However the mitochondrial free radical production of rat was considerably
higher. This clearly indicates that MLSP is not related to O2 consumption but related
to the rate of oxygen radical production.
The free radical theory of ageing has evolved. Since it was first proposed, there have
been some variations in the theory. One such idea proposed is the "mitochondrial theory
of ageing". It deals with the role of mitochondrial DNA in ageing. This theory becomes
clearer when we look at the "rate of living" hypothesis. As we saw above that there
is an indication of a negative correlation between mitochondrial free radical production
and MLSP. We will therefore concentrate on oxygen radical production in mitochondria.
Also mutations occur at a higher rate in mitochondrial DNA (Linnane et al., 1989). As
we have seen this above too, this is because mitochondria generates energy and in that
process generates ROS which causes mutation (Shokolenko et al., 2009).
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2.7. Further exploring the mitochondrial free radical
theory of ageing
We will now look further into relation between:
• Free radical or reactive oxygen species production and lifespan of species.
• Oxidative damage to mitochondrial DNA and maximum lifespan of species.
In the initial rate of living hypothesis we had seen that it was proposed that there
was a correlation between oxygen consumption (which is the metabolic rate) and MLSP
(Beckman and Ames, 1998). However this theory was revised and it was proved that there
was a correlation between mitochondrial oxidant production and MLSP (Barja, 1998; Ku
et al., 1993; Ku and Sohal, 1993; Sohal et al., 1990). Slowly ageing species were found to
have a lower rate of oxygen radical production in mitochondria and rapidly ageing species
had a higher rate of oxygen radical production.
Another great article (Barja and Herrero, 2000) has explored if oxygen radical production
is linked to oxidative damage as well. This gives a new dimension to the "mitochondrial
theory of ageing". The article tried to establish a relationship between oxidative damage
and MLSP instead of just oxygen radical production and MLSP. Oxidative damage was
measured in the form of 8-oxo-7,8-dihydro-2’-deoxyguanosine (8-oxodG) which is an ox-
idative damage marker. They discovered that there is a strong correlation between oxida-
tive damage in mitochondrial DNA and MLSP. According to their experiment, oxidative
damage in heart for mitochondrial DNA was inversely correlated with MLSP (r=-0.92;
P<0.001). MLSP was also inversely correlated with oxidative damage of mtDNA of brain
(r=-0.88; P<0.016). However they did not find a significant correlation between oxidative
damage in nDNA and MLSP (because 0.05 was selected as the point of minimum statis-
tical significance and the p-value for correlation between MLSP and oxidative damage in
nDNA in heart was P<0.06 and in brain it was P<0.27).
2.8. Thermodynamic stability of proteins
Protein stability depends on free energy change also called Gibbs free energy change.
Change in Gibbs free energy function is represented as equation 2.6 (Creighton, 1990):
∆G = ∆H − T∆S (2.6)
It gives the free energy change between folded and unfolded states. Where ∆H is the
enthalpy change between folded and unfolded states and ∆S is the change in entropy
between folded and unfolded state. The factors responsible for enthalpy are
• Bonding energies: like disulphide bonds
• Non-bonding energies: Electrostatic interactions, Hydrogen bonds and Van der
Waals forces.
We will review these terms in a bit more detail below. Likewise the factor responsible for
entropy is: hydrophobic effect.
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Gibbs free energy function for proteins can also be represented as 2.7 (Creighton, 1990):
∆G = Gfolded −Gunfolded (2.7)
Protein stability depends on free energy change between the folded and unfolded state of
a protein. The folded state is also called the native state. The more negative the value
of ∆G, the more stable the protein in its folded state. What the I-mutant program does
is (Capriotti et al., 2005)
∆∆G = ∆GWt −∆GMut (2.8)
Where ∆GWt means change in free energy of the original protein (wild type) and ∆GMut
is change in Gibbs free energy of the protein with a single site mutation. If the mutated
protein is more stable, it will have a positive ∆∆G (ddG) and if the mutated protein is
unstable, it will have a negative ∆∆G (ddG) value. The three dimensional structure of
a protein is important because it determines the functionality of the protein (Petsko and
Ringe, 2004). A protein which is not folded properly will not function correctly. The
sequence of a protein is called its primary structure. Next, due to H-bonds between N-H
and C=O of the backbone residues of the protein, there are secondary structure forma-
tions like alpha helices and beta sheets. The tertiary structure of a protein is a description
of the way the whole chain (including the secondary structures) folds itself into its final
3 dimensional shape. The tertiary structure of a protein is held together by interactions
between the side chains that is the "R" groups. When two or more polypeptide chains
come together to form a structure, it is called a quaternary structure.
We have seen above that secondary structure is formed by H-bonds. The formation of
tertiary structure is called folding of a protein and a stable tertiary structure is important
for proper functioning of a protein (Petsko and Ringe, 2004). So we should look at factors
responsible for formation of a stable 3-D structure. Some of the main factors which help
in protein folding and on which the stability of a protein depends are (Petsko and Ringe,
2004; Berg JM, 2002a):
• Electrostatic interaction: Non-covalent interaction between atoms which are oppo-
sitely charged. For example it can form between carboxylate anion (COO−) and
protonated amino group (NH+3 ) (Nelson and Cox, 2004)
• Hydrogen bond: It is a form of non-covalent interaction between a hydrogen which
is attached to an electronegative molecule (which pulls the electron cloud towards
itself thus leaving a partial positive charge on hydrogen δ+) and any atom which
has a partial negative charge δ−. In secondary structure (that is alpha helix and
beta sheets) the hydrogen bonds are formed between the peptide backbone atoms
and in tertiary structure, the hydrogen bonds form between the side chains. There
are lots of side chains which have a hydrogen atom attached to either an oxygen or
a nitrogen. They can easily form hydrogen bonds.
• Salt bridge: Salt bridges are interactions between oppositely charged amino acid
side chains (Nelson and Cox, 2004). An example is that salt bridges can form
between residues Glu− and Arg+. Both the residues are polar and charged though
oppositely charged.
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• Van der Waals force: Many amino acids have quite large hydrocarbon groups in
their side chains (eg. Leucine, isoleucine and phenylalanine) Temporary fluctuating
dipoles in one of the groups can easily induce an opposite dipole in another group
on a nearby folded chain and their force would be strong enough to hold the folded
structure together.
• Sulphur bridges: It is a covalent bond which is formed when two cysteine residues
react to form a S-S link. Like sulphur bridges between two Cysteine.
Though the non-covalent interactions listed above are weak, yet in a protein these inter-
actions are very large in number. That is why they play a very significant role in protein
folding.
The amino acids can be classified as follows:
• Non-polar, hydrophobic amino acid: Contains: Gycine (Gly) G, Alanine (Ala) A,
Proline (Pro) P, Valine (Val) V, Leucine (Leu) L, Isoleucine (Ile) I, Methionine
(Met) M, Phenylalanine (Phe) F.
• Polar, non-charged amino acid: Contains: Serine (Ser)S, Threonine(Thr)T, Tyro-
sine(Tyr)Y, Cysteine(Cys)C, Aspargine(Asn)N, Glutamine(Gln)Q
• Polar, charged amino acid: Contains: Aspartic Acid (Asp)D, Glutamic Acid(Glu)E,
Tryptophan(Trp)W, Histidine(His)H, Lysine(Lys)K, Arginine(Arg)R.
Thus we can see from the above classification that the kind of interaction between residues
would depend on the kind of amino acid and if there is a mutation in amino acid, there
will be a change in its chemical properties. It is the chemical properties that account
for various "weak forces" that were discussed above. Thus they can be disrupted and in
return can cause a change in the tertiary structure of the protein (which in return will
affect the function of the protein or can make the protein unstable).
2.9. Diseases associated with Complex I genes in
humans
2.9.1. Mitochondrial encephalomyopathy with lactic acidosis and
stroke-like episodes syndrome (MELAS)
MELAS is a neuro-degenerative disease wherein the cells lose their ability to produce
enough energy in the form of ATP (Santa, 2010). Not only is there energy deficiency, to
make up for the deficiency, the cells switch to an alternative metabolic pathway which
causes a build up of lactic acid in the body thus causing lactic acidosis (it is presence
of low pH and build up of lactate in blood and body tissues) (Sproule and Kaufmann,
2008). There is also a presence of what is known as ragged-red fibres. This is basically
a build-up of mitochondria in cells to compensate for the dysfunction of the respiratory
chain (which produces ATP)(Santa, 2010).
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Some of the symptoms of the disease are as follows (Hirano et al., 1992; Santa, 2010;
Sproule and Kaufmann, 2008):
• There are stroke like episodes that too before the age of 40 years.
• Encephalopathy manifested in the form of seizures or loss of cognitive ability or
both
• Exercise intolerance
• Lactic acidosis and presence of ragged-red fibres.
There are some other features too which are not present in all the cases and they are:
recurrent headaches and vomiting.
2.9.2. Leber Hereditary Optic Neuropathy (LHON)
The disorder starts with visual impairment in one eye with the second eye generally
following shortly (Yu-Wai-Man et al., 2009). This disorder can affect individuals ranging
from 10 to 70 years of age and it affects males and females in the 3:1 ratio (Riordan-Eva
and Harding, 1995). The peak age of onset of the disorder is however 15-30 years of
age (Yu-Wai-Man et al., 2009). The progression of the disease can be in various phases
(Yu-Wai-Man et al., 2009):
• Initially a loss in color vision is observed
• Blurring or clouding of vision in one eye. Which is generally followed by the other
eye. There have however been cases where the other eye doesn’t get affected for
long periods of time. The visual impairment is painless and the vision is 6/60.
• After the above phase, the retinal nerve fibre degenerates.
In a few patients there even has been recovery after disease symptoms have appeared.
Though the genes mutated in LHON disease are mitochondrial complex I genes (com-
plex I is involved in the respiratory chain) there is no significant affect to the oxidative
phosphorylation process (Yu-Wai-Man et al., 2009). However as they have stated in
(Yu-Wai-Man et al., 2009), the studies could be tissue specific and need to be studied
further.
Although the primary characteristic of the disease is loss in vision, there can be other
features as well: cardiac arrhythmias and neurological abnormalities (Yu-Wai-Man et al.,
2009).
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2.9.3. Leber Hereditary Optic Neuropathy with Dystonia (LDYT)
This disease too is caused by mutations in the mitochondrial genes of complex I of the
respiratory chain. The disease shows strict maternal inheritance just like LHON (De Vries
et al., 1996). The disease is characterized by vision loss like LHON as well as with dystonia
(De Vries et al., 1996; Jun et al., 1994). Dystonia is a neurological movement disorder
which is characterized by involuntary muscle contractions. In the case study in paper
(De Vries et al., 1996) the patients did not have any cadiological abnormalities however
there were neurological abnormalities.
2.9.4. Leigh Syndrome (LS)
The disorder is due to deficiency in mitochondrial ATP production (Dahl, 1998). The
symptoms can be motor or intellectual retardation, signs of brainstem dysfunction, and
other neurological disorders like ataxia, dystonia and optic atrophy (Rahman et al., 1996).
In most cases the disease is characterized by an early onset of the disease (within one year
of being born) and can cause death within two years of onset of the disease though in
some cases there is later onset and slower progression of the disease (Dahl, 1998; Rahman
et al., 1996).
Leigh syndrome is found to be due to complex I , complex II, complex III and complex IV
deficiency (Morris et al., 1996). However here we will focus on the disorder with respect
to complex I deficiency. In complex I, all genes which are responsible for the catalytic
part of Complex I except ND4L are involved in Leigh syndrome (Benit et al., 2004). The
severity of the disease varies considerably depending on the mutations that are present
(Dahl, 1998).
2.9.5. Mitochondrial Complex I deficiency (MT-C1D)
Mitochondrial Complex I deficiency is classified as an energy metabolism disorder. The
clinical features of the disease vary widely. It can cause the following diseases: (Loeffen
et al., 2000; Fassone and Rahman, 2012)
• Leigh and Leigh like syndromes (LS and LLS): Leigh syndrome presents in late
infancy with neurological problems. Clinical signs include respiratory abnormalities,
nystagmus, ataxia, dystonia and hypotonia (Fassone and Rahman, 2012).
• Cardiomyopathy: Refers to disease of the heart muscle. It is sometimes not recog-
nised because there are already severe neurological disorders present in the patient
(Fassone and Rahman, 2012).
• Macrocephaly with progressive Leukodystrophy (MLD): Leukodystrophies are white
matter disorders which present themselves as progressive neurological disabilities
(Kohlschütter and Eichler, 2011)
• Encephalomyopathy: encephalomyopathy refers to degenerative disease of the brain.
This classification is for those barin degenrative diseases which have not been clas-
sified in some disorder already.
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• Fatal Infantile Lactic Acidosis (FILA): FILA presents itself in neonatal or early
infancy. It is a rapidly progressing disease which results in death in infancy (Fassone
and Rahman, 2012).
• Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS):
The symptoms include, seizures, migraines, vomiting, exercise intolerance, proximal
limb weakness and short stature. Symptoms appear early on in childhood (Fassone
and Rahman, 2012).
The nuclear encoded genes involved in this disorder are: NDUFV1, NDUFV2, NDUFS1,
NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFA2, NDUFA11, ND-
UFA10, NDUFB3, NDUFB9. The mitochondrial genes associated are (6 mitochondrial-
encoded components of Complex I out of 7): ND1, ND2, ND3, ND4, ND5 and ND6.
2.10. Statistical Review
2.10.1. Spearman’s Rho ρ.
It is a statistical test for measuring the relationship between two quantities (variables).
This test is used when we want to measure the correlation between two variables and
they do not necessarily have a straight line relationship. However the relationship should
be monotonic. Monotonic means that the relationship is either entirely non-increasing
or nondecreasing and is not for example like a ’U’ turn (Weisstein, 2011). An ex-
ample showing a monotonically decreasing function is figure 2.4 and an example of a
non-monotonic function is figure 2.5. Spearman’s rank correlation coefficient is a non-
parametric method.
Figure 2.4.: Monotonically decreasing function. Source: (Oleg, 2007a).
15
2. Review of Literature
Figure 2.5.: Non-Monotonic function. Source: (Oleg, 2007b).
2.10.2. Parametric and non-parametric methods
When we cannot make an assumption about the shape of the distribution of measure-
ments, we have to use methods which do not depend much on the shape of the distri-
bution. These methods are non-parametric methods (Mosteller et al., 1983). They are
called non-parametric because their behaviour does not rely a lot on the shape of the
distribution (Mosteller et al., 1983). In non-parametric tests, very few assumptions are
made about the distribution of the data and in particular, the data is not assumed to
follow a normal distribution (Clarke and Cooke, 1998).
Some of the non-parametric methods are based on ranks or counts of objects or different
sign assignment. Example of a method based on ranks is Spearman’s ρ and based on
counts of objects is median determination. And an example of method based on sign
assignment can be that given a distribution, we assign a positive sign to all the numbers
which are above a set threshold and a negative sign to all the numbers below a threshold.
Then in such a case if we change the value of a number which was above the threshold
to some value 10 times higher, the distribution will change, the mean and variance will
all change however there will be no change in the sign assignment to the distribution.
The ranks of the distribution as well as the median will not change. This example was
mentioned in the explanation of non-parametric methods in (Mosteller et al., 1983).
Non-parametric methods are said to be resistant and robust (Mosteller et al., 1983).
Example of resistance can be seen by the example discussed above (the median, sign
and ranks did not change hence the term resistant for non-parametric methods). Non-
parametric methods are robust meaning that where a parametric method can be used
(that is based on the shape of the population we can use a parametric test) there, if we use
a non-parametric method, we will lose very little information about the data. Parametric
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methods on the other hand are based on the normal distribution which is also called a
parametric distribution (Clarke and Cooke, 1998).
2.10.3. Spearman’s correlation coefficient in a bit more detail
Spearman’s rank correlation coefficient. Denoted by Rho ρ. Shows the statistical depen-
dence between two variables.
First the data is ranked. Both the variables are ranked separately (Hollander et al.,
2013). Suppose the the variables are height and age, then we rank them separately. In
case there is a tie in value then we take an average of the ranks. Suppose two people have
height 150 cm and the ranking till then is 4 then they both get a rank of 5.5 instead of
one having a rank of 5 and other 6. Once we have calculated the rank in this manner, we
use the following equation to calculate ρ, where xi and yi are ranks from our data. The
equation for ρ is:
ρ =
∑
i(xi − x¯)(yi − y¯)√∑
i(xi − x¯)2
∑
i(yi − y¯)2
(2.9)
Another method to calculate rho is given by equation 2.10 (Maritz, 1995). This equation
is used when there are no duplicate values in rank. Here di = xi-yi and n is the number
of pairs or sample size.
ρ = 1− 6
∑
i d
2
i
n(n2 − 1) (2.10)
Determining ρ by itself is not sufficient. We need to determine the significance of the ρ.
For determining significance, we can use the Student’s t distribution given by equation
2.11.
t = r
√
n− 2
1− r2 (2.11)
Where n-2 is the degree of freedom and n is the sample size.
2.11. I-mutant program and SVM
We used I-mutant program to find the relative stability of proteins after mutation. To
understand the I-mutant program, we first need to understand Support Vector Machines.
Support Vector Machine (SVM) is an algorithm which can be used for assigning contin-
uous values or just assigning discrete labels. For example we use an SVM for an amino
acid secondary structure prediction given the primary sequence or predicting the stability
of a protein given the primary sequence and the single point mutation that is made to the
original protein. In simpler terms, we can say that an SVM algorithm produces a model
(based on training dataset) to predict class labels for test dataset (Hsu et al., 2003). For
example in email classification task, there will be several features in each training dataset
sample (which determine whether the email should be labelled as spam or non-spam).
The spam and non-spam value is the label. There will be one label per input sample and
the sample will have various features like occurrence of certain words or capitalization of
words and the like. There will be certain datasets called training dataset which will be
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used to train the algorithm or model (labels are available for it) and test dataset which
is used to verify the model. Test dataset is a dataset which is similar to the training
dataset however has no overlapping values. We also have labels for this dataset and we
use the labels to verify the value predicted by our model. Once the prediction accuracy
is good on the training dataset, the model can be used on an actual dataset. Training
is a process by which a model assigns certain parameters like weight or bias so that the
model can be used for actual dataset.
To explain the working of SVM in detail here, we will focus on SVM as a binary classifier.
SVMs are of two types (Steeb, 2011):
1. Linear decision boundaries.
2. Non-linear decision boundaries.
2.11.1. Linear decision boundaries
Suppose our dataset is separable into two classes. Then in linear decision boundary, the
data will be easily separable into the two classes by two margins which are parallel to the
hyperplane (Steeb, 2011).
Hyperplane: Suppose we have an n-dimensional space then in that n dimensional space,
a flat of (n-1) dimensions is called a hyperplane (Stanley, 2004). A hyperplane is a sub-
space of dimension one less than the dimension of the whole space (Heden et al., 2013)
Suppose we have a two dimensional data which is clearly separable into two classes (that
is it is linearly separable). Then in that case the hyperplane would be a straight line. In
practical applications, our data is not two dimensional. Likewise for a three dimensional
data, the hyperplane would be a two dimensional plane.
For a space, there are several hyperplanes (Heden et al., 2013). However the main aim of
SVM is to find the optimal weight and bias parameters such that hyperplane correspond-
ing to them separates the positive and negative training data with maximum margin
(Steeb, 2011).
2.11.2. Non-linear decision boundaries
Here the data is not linearly separable that is no hyperplane to separate the data. In
such a case, one procedure for classification could be to use a higher order polynomial
feature vector (Ng, 2012; Burges, 1998). Suppose our input vector has two features x1
and x2 with a binary classification. The data type can be such that it is not separated
by a straight line but instead by a circle or ellipse or some other irregular shape. Thus in
this case, we will not be able to separate data simply by using x1 and x2 but will have to
use a combination of terms like x1x2, x21,x22 and the like. This is simply when there are
two features in our input vector (Ng, 2012). As the dimensionality of the vector increases,
the complexity of the polynomial terms will also increase. Besides manually selecting the
features would be cumbersome.
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Thus a better method would be to use kernels (Steeb, 2011). The data (training data) is
mapped to a higher dimensional space by a function φ such that it is transformed into
a linear decision boundary problem and then a maximum margin hyperplane separating
the data can be found just like for linear decision boundary problem (Steeb, 2011; Hsu
et al., 2003). The kernel function is as: K(xi, xj) ≡ φ(xi)Tφ(xj). We don’t have to worry
about φ since we will be using kernels directly without focussing on φ.
Some of the common kernels are as follows (Hsu et al., 2003)
1. Linear: K(xi, xj) = xTi xj
2. Polynomial: K(xi, xj) = (γxTi xj + r)d, γ > 0
3. Radial basis function(RBF): K(xi, xj) = exp(−γ||xi − xj||2), γ > 0
4. Sigmoid: K(xi, xj) = tanh(γxTi xj + r)
γ , r and d are all kernel parameters. (xi, yi) is the training set where i = 1, ...., l, xi ∈ Rn
(meaning there are l training samples and each sample has n features) and y ∈ {1,−1}l.
2.11.3. I-mutant
I-mutant is a tool for predicting the protein stability upon single site mutation. It is a
machine learning algorithm and uses support vector machines. The program can be used
in two ways:
• Where we know the tertiary structure of our protein
• Where we only know the primary sequence of the protein
For I-mutant program, the accuracy of stability prediction in case of just primary sequence
availability is 77% (Capriotti et al., 2005) The program predicts the stability by giving
the relative stability change (ddG) value of the protein when a mutation is applied to
it at any amino acid site. This process is composed of two parts: predicting sign of
ddG value and predicting the actual ddG value. In the first method, it tells whether the
mutation has caused the protein to become stable or unstable. In it, the magnitude of
the relative stability change is not taken into account. In fact in many applications, the
sign of relative stability is more important than the actual magnitude of (ddG) (Cheng
et al., 2006).
The dataset to train the support vector machine(SVM) and to test it is obtained from
ProTherm database (Gromiha et al., 2000). Further they have extracted the tertiary
structure information about the proteins from Protein Data Bank (Berman et al., 2000).
They selected data from ProTherm in such a manner that only proteins with single point
mutations were selected and those values were selected where the protein stability change
(ddG) was experimentally determined with known experimental conditions.
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The program works for both cases: where only sequence is available and where sequence
and structure both are available. We get to choose the position and new residue as well
as the temperature and pH values. If we are not dealing with changes in temperature and
pH we leave those two parameters as such (the default values are pH 7 and temperature
25 ◦C. In our case we made no change to the default pH and temperature values).
For the encoding scheme, they have an input vector with 42 values. The first two values
of the vector correspond to temperature and pH at which the stability of the mutated
protein is measured. Next 20 values are used to represent the amino acids. The amino
acid which will be mutated is assigned a value of -1, the new amino acid is assigned a
value of 1 and the rest of the positions corresponding to the remaining 18 amino acids
are assigned a 0. The next 20 input values serve different purposes when the sequence
structure is known and when just the sequence is known. Since our usage of the I-mutant
program deals with just sequences, we will look at that case. It is used to represent a
total of 19 amino acids including the mutated residue. Thus we can say that we consider
a window of size 19 for this program. The input vector is generally called a feature
vector. Each input vector would also have a corresponding (ddG) whose value would be
known. Several of such feature vectors and corresponding (ddG) value (or sign when we
just have labels) will compose a training data and test data. The kernel used is radial
basis function(RBF) which is: K(xi, xj) = exp(−γ||xi − xj||2), γ > 0 (Capriotti et al.,
2005). The function f(x) for SVM is defined as 2.12 (Cheng et al., 2006; Burges, 1998).
f(x) =
∑
xi∈S+
αiK(si, xi)−
∑
xi∈S−
αiK(si, xi) + b (2.12)
f(x) is the predicted value of (ddG) and simply the sign of f(x) will be enough to classify
the data as: stable after mutation or unstable after mutation (Cheng et al., 2006). S+
denotes data points where (ddG) > 0 and S− denotes (ddG) < 0. αi is the non-negative
weight assigned to the training data, b is bias and si is the support vector.
Thus to understand si, we need to understand what a support vector is. While training,
there is a sub-set of the training data that is very close to the hyperplane separating the
dataset into the two labels (in case of a binary classification task). Classifying such data
points is a bit tricky since they lie close to the separating hyperplane. Thus they could
be classified on either side. However their correct classification is essential for the SVM
to make a correct prediction. This training data subset plays a determining role while
modelling the SVM (that is in the learning of the weight and bias vector). This sub-set
of training data is called the support vector (Alpaydin, 2004).
After training, the weight vector can be written down in terms of this training data
sub-set. As we know, there are many separating hyperplanes for the same training data.
However the main aim of a Support Vector Machine is to find the optimal weight and
bias parameters such that hyperplane corresponding to them separates the positive and
negative training data with maximum margin (Steeb, 2011).
What is provided to us users is a trained SVM which can be used for the prediction of
protein stability upon single site mutation. The user can provide the site of mutation
and the new amino acid (as well as change in temperature and pH) and the program
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will predict the relative stability change. The program can be accessed from its web-
site (http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.
cgi) (Capriotti et al., 2005)). In our case we had to make stability prediction for a large
dataset so we used the program in our department cluster. We used I-mutant 3.0 and
we just used the sequence only option because we did not have tertiary structure avail-
able for our sequences. For the tests that were made by the designers of I-mutant, the
accuracy for sequence only data (we need the sequence only case because our dataset is
sequence only) is 77%. In the I-mutant program, a positive (ddG) value indicates that
the protein is stable after the mutation and a negative (ddG) value indicates that the
protein is unstable after the mutation.
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The objectives of our study are as follows:
1. Check if there is a significant correlation between the stability of complex I proteins
and MLSP of the species which have that protein. That is find if proteins in
Complex I emulate the MLSP and oxidative damage correlation.
2. Check if there is a difference between complex I proteins: the "core" proteins of
complex I which are involved in catalysis and those with non-catalytic properties.
In short we want to check if the proteins which belong to "core" of complex I are
in any way more or less stable than the rest of the proteins or vice versa.
3. Check if there is a difference between proteins encoded by the mitochondria and
nuclear encoded proteins when it comes to protein stability vs MLSP relationship.
4. We will apply three different methods to check for the stability of proteins. So we
will check how many proteins behave similarly across the three methods.
5. Make pair comparisons between methods and find similarity or differences in the
behaviour of proteins across the different methods. For example we will compare
the positive correlation result of one method with the positive result of another
method. Likewise for negative correlation values. We will also check if for a protein
there is a positive correlation between stability and MLSP by one method and a
negative correlation by another method.
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4.1. Tools
4.1.1. Perl, BioPerl, Ensembl and Perl API
Perl: The scripting language used in the initial phase of the project wherein we had to
download all the orthologs of the human genes for Complex I was done using Perl. We
used Perl 5 (http://www.perl.org) because that was compatible with the Ensembl API
version we used. We had the requirement to use Perl because we were accessing Ensembl
database via its Perl API.
BioPerl: BioPerl (bioperl.org) is an open source project which provides bio-informatics
modules for use with Perl. The tool-kit is written completely in Perl (Stajich et al.,
2002). We did not use BioPerl directly but we used Ensembl Perl API which makes use
of BioPerl. For our use, BioPerl version 1.2.3 was used. Like Perl, it can be used in Unix,
MacOS or Windows.
Ensembl and Perl API: There are three methods to access the Ensembl database:
Usings APIs:Perl or REST, through MySQL and Via BioMart. For our requirement the
best option was to use Perl API. It has a middle level of learning required and ease of
data extraction. We wanted to extract the orthologs of all the genes in our list. To use
Perl API, we need to install the API and also install BioPerl version 1.2.3. While using
Perl we do not have to know much about the database schema of Ensembl but we have
sufficient power to extract any information that is present on the website. We indirectly
queried the Ensembl core database. Since we used the API we did not need to know
the database schema. There is also a short Ensembl API tutorial provided which makes
using the API slightly easier (http://www.ensembl.org/info/docs/api/core/core_
tutorial.html).
4.1.2. Shell scripting
We used biocluster.uta.fi for mutating our protein using the I-mutant program. The task
of submitting the jobs to the I-mutant program was done using Unix shell scripting. We
also used shell scripting to compile the needed information from the files generated by
the I-mutant program.
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4.1.3. Python, Biopython, Beautiful Soup
Python: We used Python (https://www.python.org/) an open source scripting lan-
guage for simple operations like removing ortholog sequences which are incomplete (which
had Xs) and making a fasta file from the protein sequences that were extracted from
Ensembl. Apart from that we had to extract the list of species names from the or-
tholog sequences list and then find its corresponding MLSP from (http://genomics.
senescence.info/species/). To extract MLSP from the website, we used Beautiful-
Soup which needs Python and Numpy installed. I have used Python 2.7 because Beautiful
soup and Biopython modules work well with it.
Biopython: It is a freely available open source tool for common Bio-informatics tasks
(http://biopython.org/). Biopython has modules for interacting with various tools
like BLAST, ClustalW and EMBOSS. It can access various online databases like Entrez
and ExPASy and read and write different sequence file formats and perform several
operations on them (Cock et al., 2009). Biopython can be used on major operating
systems like Unix, Mac OS and Windows. We have used BioPython on Ubuntu (a Linux
based operating system). Version used is biopython-1.63. To use Biopython, we need
Python and NumPy installed. We used the module to download information about all of
our 45 genes from Entrez.
Beautiful Soup: It is a Python library used to extract information from HTML and
XML files (Richardson, 2007). We used it to extract MLSP value for our ortholog species.
We used Beautiful Soup 4. Instead of manually searching for each specie name on the
web to extract its MLSP, we used Beautiful Soup 4 to extract that information along
with extracting the common name of the organism.
4.1.4. R: Statistical analysis tool
R is a free software programming language used for statistical analysis (http://www.
r-project.org/). It can be used on all platforms like Unix, Mac OS and Windows
(Hornik, 2014). I used R version 3.0.2 on a Linux system.
4.1.5. I-mutant
The I-mutant program was installed in biocluster50 (bc50) which was reachable from
Biocluster.uta.fi. We used shell scripting to perform mutation at each site for all the
orthologs of all the proteins. Each site was mutated to 19 possible amino acids. We
had a separate file for each site mutation which consisted of ddG value of the protein
for each of the 19 possible mutations for that site. Once we had all the mutation files,
we used shell scripting to extract information from those files so that we had a single
file for a single ortholog. This file contained information compiled from all the site files
of that ortholog. This site had the wild type amino acid value, the sum of positive and
negative mutations for each site and the number of positive and negative mutations for
each site. I sshed this compiled information to my Linux system on which R version 3.0.2
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was installed and it was used for data analysis.
4.2. Methods
4.2.1. Overall procedure
The overall procedure applied for the study is as follows:
1. Download the protein sequences of all the orthologs for all the genes in our gene list.
(Our gene list has genes which form a part of Complex I of the electron transport
chain).
2. Remove those protein sequences which are incomplete (these are sequences which
have Xs in their sequence) These make up less than 5% of the orthologs.
3. Submit the protein sequences to I-mutant program. Apply all possible mutations
at each site for each ortholog.
4. There is one file per site containing all 19 possible mutations for the protein (the
file contains information of whether the mutation was destabilizing or stabilizing).
There are however as many files per ortholog as there are sites in it. So we combine
information from all sites for that ortholog and write it to a single file. The file
name contains species name as well as the Ensembl Id for that transcript of the
ortholog.
5. Once we have one file per ortholog, we extract the information we need: The
wild type Amino acid, the number of stabilizing mutations (mutations which give a
positive ddG value), the number of destabilizing mutations (mutations which give a
negative ddG value), the sum of stabilizing ddG values and the sum of destabilizing
ddG values.
6. Make a list of all the species for which we need to find the Maximum Life Span
(MLSP).
7. Find the Maximum Life Span(MLSP).
8. Find general information about all the 45 genes from Entrez (from this information,
we will extract information about the diseases associated with these genes and which
gene is involved in which disease).
9. Use the MLSP and the files with extracted I-mutant information in R to find if a
relationship exists between the stability of the proteins and the MLSP of the species
for the various electron transport chain Complex I proteins that we have.
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4.2.2. Get all the orthologs for each human gene in our gene list
This program was written in Perl using Ensembl Perl API. It was used to extract all
the homologs for each gene in our gene list. We extracted information for all homologs
but didn’t write the paralogs for the human gene (since we only need orthologs in our
analysis.)
Algorithm 1 Get all the orthologs for all the genes
Require: Open the file with Ensembl gene Id names
while stable Id in file with human Ensembl gene Ids do
Import Registry module (This is the module that helps connect to the Ensembl
database)
Then make a connection to the Ensembl Registry
Obtain the Gene adaptor using Registry (with species name as ’Human’ and
database type as ’Core’) (Gene adaptors are object adaptors which can be used to
extract information from the Ensembl database)
Use Gene adapter to fetch the Gene by its stable Id
For the Gene extract the canonical transcript
Get all the homologs for the human transcript
Create one fasta file for one gene Id (this file will have all the homologs of the
human protein sequence)
Create description for fasta sequence for human protein by concatenating Ensembl
gene Id and species name (here homo sapiens) with symbol "_" as a separator in
between the Ensembl Id and species name
Write the description line
Write the translation of the canonical transcript extracted
for Each homolog in homologs do
Obtain species name from the homolog information
Obtain new Gene adaptor using Registry (with species name as obtained by the
homolog and database type as ’Core’)
Use the Gene adapter to fetch the Gene by its stable Id
For the Gene extract the canonical transcript
If the translation for the transcript is defined, we define the description line for
the species (to add to our homologs fasta file)
Write the description line
Write the translation (of the canonical transcript extracted )for the species to the
homolog file too
end for
Close the gene homologs file
end while
Close the file with Ensembl gene Id names
4.2.3. Remove incomplete protein sequences
Incomplete sequences are those which have ’Xs’ in the sequence. Those are sites for which
the amino acid is not known. There are, on average, less than 5% of sequences which
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fall in this category. Those sequences were removed from our fasta files. The script for
removal of incomplete sequences was written in Python.
Algorithm 2 Remove incomplete protein sequences
function removeX(name)
Open file with name in read mode
Open another file in write mode (for files without X character in sequences)
for line in file do
if line is odd numbered then
description = line
else if sequence line has no ’X’ then
Write the description line corresponding to this sequence to file
Write the sequence line to file
end if
end for
Close both files
end function
Require: Open file with all fasta file names
for name in file do
removeX(name)
end for
Close file
4.2.4. Submission of protein sequences to the I-mutant program
We use shell script for the purpose of submitting our jobs to Biocluster for execution
by I-mutant. We make use of a cluster here. When we can divide a task into multiple
smaller tasks which can be executed in parallel, then we make use of clusters. Clusters
are basically large number of computers which are also called nodes. There are different
softwares that manage jobs between the systems. The jobs are submitted in a queue.
The name of the cluster in our lab was Biocluster which had 50 nodes and out of these
50 nodes, 23 were assigned for mutating sequences by I-mutant program and finding the
stability of the mutated protein. To submit jobs in a cluster, we login to any one node
and submit our jobs. I submitted my jobs from bc50 (which was biocluster 50) which
was accessible from biocluster.uta.fi.
First we use a shell script which creates different directories for different Ensembl Ids and
invokes the script that makes setting changes to the cluster and submits jobs to it. The
algorithm for it is given by Algorithm 3. Each directory will contain files produced by
the I-mutant program.
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Algorithm 3 Submission of orthologs to I-mutant program for mutation
Require: Open the Ensembl Ids file
for stable ensembl Id in the file of Ensembl Ids do
Make a directory with ensembl Id as name
Copy the fasta file with that ensembl Id name into that directory
Change directory to the newly created directory
Extract all descriptions from all the fasta sequences from the fasta file
These descriptions minus the ">" symbol form the names of the protein files whose
sequences will be submitted to the I-mutant program
Execute the shell script which makes settings in the cluster and submits jobs to
the cluster. (How changes to cluster settings is made and what are the various jobs is
discussed below)
end for
For making settings to bc50, we had used PBS which is a job resource manager. It is used
on clusters and provides queuing facility and job execution services. There are several
job queues. We used the queue named "batch". Each queue has a "maximum walltime".
Walltime basically means that if any job submitted to it takes more than the "walltime",
the job is terminated. In our case, a walltime of 24 hours was allotted (however each job
in our case just took a few seconds). We make these setting by a PBS script which is
basically just a normal unix script with some comments in the beginning which are called
PBS directives. These are comments that start with #PBS. We can use the following
commands to make some settings:
• #PBS -l walltime=HH:MM:SS
• #PBS -l nodes=N:ppn=M
• #PBS -q queuename
In #PBS -l nodes=N:ppn=M, nodes=N specifies the number of nodes and ppn=M spec-
ifies the number of processors per node. In our case we had not specified any processors
but just the number of nodes (which was 23).
We used qsub to submit our jobs and after submitting the jobs, we could monitor the
jobs at any time using mon and qstat. In our case the mutation of proteins (each site gets
mutated by the remaining 19 amino acids for all the orthologs for each Ensembl human
protein of complex I). Each mutation that is applied to a site calls the I-mutant program
and is treated as a job. Each job is assigned a process Id and is submitted to one of the
nodes of the cluster.
We submitted the bash file with an & in the end so that the processing of the script can
continue even after we have logged out from the server. This is because not all the jobs
get submitted to the queue in one go but it is an ongoing process where mutations are
created and they are submitted to the I-mutant program and the result obtained and
stored in a file such that there is one file per site of a protein. That one site file contains
information about the stability of the protein for each of the 19 mutations that can be
applied at that site.
28
4. Tools and Methods
4.2.5. Extract information from files produced by I-mutant
For each ortholog, there are n number of files (created by the I-mutant program) where
n is the number of sites in that protein sequence. So first we run a bash script that
concatenates the information of all the n files into one file. Each such concatenated file
is then processed by a perl script which parses the I-mutant file and extracts information
from it. What the perl script does is that it finds the wild type amino acid for each site
of the protein sequence (from the .out file) passed to it, along with the sum of positive
(ddG) values, sum of negative ddG values, number of positive ddG mutations and number
of negative ddG mutations per site. These files along with the MLSP file is used for data
analysis in R. The algorithm for the Perl script is as follows:
Algorithm 4 Extract information from concatenated I-mutant files
Require: open the I-mutant concatenated file
for each line in file do
if a match with " Position" pattern is found (this is because position is found only
in the beginning of each site ) then
Read the next line and split it so as to obtain AA position, wild type AA at that
site, new AA after mutation.
Initialize npos (number of mutations with positive ddg value at that site) to 0
initialize nneg (number of mutations with negative ddg value at that site) to 0
Initilize sumneg and sumpos to 0 as well
sumneg is sum of negative ddG values for a site
sumpos is sum of postive ddG values for the site
end if
if a match with " DDG Value Prediction:" pattern is found then
if the ddG value is greater than 1 then
Increment the npos by 1
Add the value of positive ddG mutation to sumpos
else
Increment the nneg (number of negative ddG values) by 1
Add the value of negative ddG mutation to sumneg
end if
end if
if a match with an http pattern is found then
Make a single record with position of AA, the wild type AA, sumpos, npos, sumneg,
nneg.
This is information for one site
Write the record to a file which has information about all sites of the protein (for
that particular species)
end if
end for
We now have a single file with information extracted from the I-mutatnt file for a partic-
ular protein, for a particular species.
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4.2.6. Collect names of species for which we have protein
sequences
We need to collect the names of all the species for which we have protein sequences
available because we need to extract the MLSP of those species (which we will need in
our further analysis with R). The script for extraction is written in Python. The name of
the species is mentioned in the description row of the fasta sequences. The description line
starts with the symbol ’>’. The Ensembl Id and the species name form the description
line and the two are separated by an "_" symbol. We use this information to extract the
species name. The algorithm for it is given below.
Algorithm 5 Extract species name
function extractSpecies(line, speciesList)
Find position of "_" symbol call it position
Species name is a slice of line from position + 1
if the species name is not in speciesList then
Add the species name to the speciesList
end if
end function
Require: Open file with list of genes in read mode
Open a new file to which we will write names of species
speciesList = [] (empty list)
for gene name in file do
Open the fasta file with the gene name (this has all the orthologs of the human
gene by that name)
for line in the fasta file do
if first element of line is ’>’ then
extractSpecies(line, speciesList)
end if
end for
Close the fasta file that was opened
end for
Write the species name to file
Close file with species name
Close file with gene names
4.2.7. Extract MLSP
Maximum Life Span of species has been extracted from (Tacutu et al., 2013).The script
is written in Python and makes use of Beautiful Soup and requests. Both are Python
libraries. Requests is an HTTP library and Beautiful Soup is a library for extracting
data out of HTML and XML files. Here requests is used to obtain web page content and
then Beautiful Soup is used to parse the webpage to extract required data from it. Apart
from this we take
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Algorithm 6 Extract MLSP
Require: Import BeautifulSoup and requests
function extractwebpage(base url, species)
In species name, replace " " with a "+"
New url is base url + new species name
Request a session
Requests.session is used to obtain the content of the webpage whose url we have
We create a BeautifulSoup object on the webpage content
Find all the "td" tags in the webpage using Beautiful Soup object
for row in rows with "td" tag do
if row has "em" tag too then
val = row, where text is True
add val to an empty info list
val contains value of MLSP and common name of species
end if
end for
return info
end function
Require: Define the base url from which information has to be extracted
Open file with species name
Open maximum lifespan file to which info extracted from webpage will be written
for species in the species name file do
Speciesinfo = extractwebpage(base url, species)
Convert Speciesinfo extracted from function to string
Write to maximum life span file
Wait for 6 seconds and then continue
end for
4.2.8. Fetch Entrez Information
To be able to extract all possible information about our genes from NCBI, we used a
python script (which also used Biopython) to extract information about the human genes
in our gene list. The information mainly consisted of the diseases the genes are involved
in. This was important to get a better idea of our genes and to see which out of the 45
genes had been researched more and had actual diseases associated with it. We could
get the general idea of the diseases associated with the genes just by looking at a few
genes but for an exhaustive list we had to look at each gene individually. Instead of the
cumbersome task of looking up each gene in NCBI (http://www.ncbi.nlm.nih.gov/)
we used Python and Biopython to extract the required information.
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Algorithm 7 Fetch Entrez Information
Require: Import Entrez and SeqIO from Bio (part of Biopython)
Open the gene Ids file in read mode
Open the file to which we will save the gene information (in write mode)
for gene in gene Id file do
In the protein database of Entrez, search for "Gene" and "Organism" where
"Gene" is the gene name from file and "Organism" as human.
Once we have obtained the handle by the above method, we read the record and
from there get the gene Id used in Entrez for that gene for humans.
We use that gene Id to fetch the record from Entrez using the protein database.
We get our required information from the comments section of annotations of the
sequence record.
We write it to a file
end for
Close both the files.
4.2.9. Analysis of data by R
We use R to find Spearman’s correlation co-efficient and p-value as well as to get various
scatter plots depicting the relationship between the MLSP and stability of proteins. The
data is analyzed in three ways. We have a file for each ortholog which consists of the
wild type amino acid at each site along with how many stabilizing mutations occur at
that site, how many destabilizing mutations occur at that site, the sum of the stabilizing
mutations and the sum of de-stabilizing mutations. From this information, we have made
three different types of analysis.
1. In the first case, we find the mean value of ddG for each site and then the mean value
for the whole protein. We then find the Spearman’s correlation coefficient between
the mean ddG value and the MLSP of the species (along with the p-value). We
also make scatter plots for all the 45 genes.
2. In the second case we find the mean ddG value for each site and then pick the
minimum value of ddG among all those sites for the whole protein (we have picked
the most destabilizing mutation for the whole protein) and then find the Spearman’s
correlation coefficient and scatter plots as we had done before.
3. In the third case, we use a ratio of number of stabilizing mutations for the protein
and length of the protein. This is because the paper (Cheng et al., 2006) mentions
that in many cases, the sign of ddG matters more than its actual magnitude. Even
if we consider this particular case, by just taking into account the ratio of stabilizing
mutations and length of protein, we get the general idea of how stable a protein is
after mutations.
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5.1. The sub-cellular location of proteins
We used Biopython to collect information about the complex I genes (on our list) from
Entrez (Maglott et al., 2005). We then parsed that information to obtain sub-celluar
location of all the genes for which the information was available. For our list of 45 genes,
sub-cellular location of 34 genes was available. The information obtained is given in table
A.7 in Appendix. We also parsed information from the file to find out the list of diseases
in which Complex I proteins are involved. The diseases from the list have been discussed
in review of literature chapter. From the information along with the names of diseases,
I collected the genes responsible for the various diseases which have been discussed in
subsection 5.2. I cross-referenced the gene list of each disease from OMIM (omi, 2014).
Explanation of the various sub-cellular locations are as follows:
• Peripheral membrane proteins: They are attached to the exterior of the lipid bilayer.
They can be removed without harming the lipid bilayer. It is in stark contrast to
integral proteins which are embedded within the lipid bilayer. (Integral proteins
can be transmembrane in which case they extend through the membrane. In this
case part of the chain is in the bilayer and part of it is outside. The hydrophobic
parts of the protein are inside the membrane and hydrophilic parts are outside).
• Single-pass membrane protein: It is a transmembrane protein where the polypeptide
chain goes through the membrane only once. They thus have their C terminus and
N terminus at opposite ends
• Multi-pass membrane protein: It is a transmembrane protein where the polypeptide
chain goes through the membrane more than once.
5.2. The diseases associated with complex I genes
The diseases Complex I genes are involved in are as follows: (This information was parsed
from protein information extracted for all the genes from entrez using biopython) (have
not listed the generic symptoms that are caused by some genes but complete diseases
caused by them)
• Mitochondrial Complex I deficiency (MT-C1D)
• Leber Hereditary Optic Neuropathy (LHON)
33
5. Results
• Leber hereditary optic neuropathy with dystonia (LDYT)
• Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syn-
drome (MELAS)
• Leigh syndrome (LS)
• Alzheimer disease mitochondrial (AD-MT)
5.2.1. Mitochondrial Complex I deficiency (MT-C1D)
As per the gene information downloaded from entrez we get to know that the OMIM Id of
the disease is: 252010 and that the following genes are involved in Complex I deficiency:
NDUFV1, NDUFS1, NDUFS2, NDUFS4, NDUFS7, NDUFA1, NDUFA11, MT-ND6,
MT-ND3 and MT-ND5. As per OMIM databse, the Complex I genes involved in Mito-
chondrial Complex I deficiency are as follows: NDUFS2, NDUFB3, NDUFS1, NDUFS6,
NDUFS4, NDUFB9, NDUFS3, NDUFV1, NDUFV2, NDUFA11 and NDUFA1.
5.2.2. Leber’s Hereditary Optic Neuropathy (LHON)
The genes involved in this disease are as follows: ND1, ND2, ND6, ND5, ND4 and ND4L.
This information is extracted using biopython program which uses entrez (Maglott et al.,
2005) and cross-referenced manually with (omi, 2014). As we see above all the genes are
mitochondrial genes. The OMIM Id of the disease is: 535000.
5.2.3. Leber Hereditary Optic Neuropathy with Dystonia (LDYT)
Genes involved in LDYT are as follows: ND1, ND6, ND4 and ND3. The OMIM Id of
the disease is: 500001.
5.2.4. Mitochondrial encephalomyopathy with lactic acidosis and
stroke-like episodes syndrome (MELAS)
As per OMIM the Complex I genes responsible are: ND1, ND5, ND6. As per information
extracted from entrez the genes involved are: ND1, ND4, ND5, ND6. From entrez, we
get to know that the OMIM Id of the disease is: 540000.
5.2.5. Leigh Syndrome (LS)
Leigh syndrome is caused by deficiency in Mitochondrial complex I, II, III, IV and V.
Here however we have just discussed it in terms of Complex I. The Complex I genes
involved in Leigh syndrome (as per OMIM) are as follows:
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• NDUFA2 : Leigh syndrome due to mitochondrial complex I deficiency
• NDUFS3 : Leigh syndrome due to mitochondrial complex I deficiency
• NDUFS8 : Leigh syndrome due to mitochondrial complex I deficiency
• NDUFA9 : Leigh syndrome due to mitochondrial complex I deficiency
• NDUFA12 : Leigh syndrome due to mitochondrial complex I deficiency
• NDUFS7 : Leigh syndrome due to mitochondrial complex I deficiency
• NDUFA10
• NDUFS4
As per information extracted from entrez the genes involved are as follows: NDUFV1,
NDUFS7, NDUFS8, NDUFA12, ND3 and ND5. The OMIM Id of the disease is: 256000.
5.2.6. Alzheimer Disease Mitochondrial (AD-MT)
As per information extracted from entrez, the genes involved in this disease are as follows:
ND1 and ND2. The OMIM Id of the disease is: 502500.
5.3. Results of statistical analysis
The MLSP of all the species involved is given in appendix A.1 and A.2. Anywhere in
this thesis, where MLSP term is used, it means MLSP of the species in years. We have
also removed Homo sapiens from the graphs because MLSP for humans is 122.5 years
which is much higher than the second highest MLSP (almost double) thus it was making
reading and analysing of graphs difficult.
5.3.1. Analysis for mean of mean of ddG
In mean of mean of ddG, we take mean ddG value at each site and then we take the
mean ddG value of all sites and that is considered the stability of the protein. Greater
the value, more stable the protein. To find the correlation, we use Spearman’s correlation
coefficient which is given by ρ. And to find the significance of each of the ρ, we have
also listed the p-value associated with it. Here, there are 11 proteins with p-value less
than 0.05 (which we set as the threshold). They are given in table 5.1 with their ρ and
p-value.
Out of these 11 proteins, 5 proteins have a positive value of ρ. That means for those
proteins, the relative stability value ddG increases with increase in MLSP. These pro-
teins are: NDUFS8, ND2, NDUFB4, NDUFB6 and NDUFB10. The plots for ND2 and
NDUFB6 are given by figure 5.1 and discussed below. The rest of the plots with posi-
tive correlation are given by B.1 in appendix. Proteins with negative ρ are: NDUFS1,
NDUFS3, NDUFS5, NDUFA6, NDUFB5 and NDUFC2. That means for these proteins,
the relative stability value ddG decreases with increase in MLSP. The plots for NDUFA6
and NDUFC2 are given below by figure 5.2 and discussed below. The rest of the plots are
given by figure B.4 in appendix. The complete table for ρ and p-value for this method
is given by table A.4 in appendix. Significant p-value values (11 proteins) are marked in
blue color.
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(a) ND2: ρ=0.62, p-val=0.01348 (b) NDUFB6: ρ=0.52, p-val=0.00172
Figure 5.1.: Relationship of mean mean ddG and MLSP with positive correlation
genes ρ p-val mean of mean
NDUFS1 -0.44 0.01348
NDUFS3 -0.35 0.04199
NDUFS8 0.45 0.00716
NDUFS5 -0.37 0.02835
NDUFA6 -0.58 0.00017
ND2 0.62 0.00177
NDUFB4 0.34 0.04872
NDUFB5 -0.46 0.00569
NDUFB6 0.52 0.00172
NDUFB10 0.45 0.00543
NDUFC2 -0.55 0.00328
Table 5.1.: Rho and p-value for mean of mean ddG
In figure, 5.1a we see that there is a strong positive correlation between mean mean
ddG and MLSP for protein ND2. Meaning that the greater the stability of ND2 for an
organism, the higher the MLSP for it. In the graph, the four lowest ddG values are:
-1.0078, -0.9804, -0.9793 and -0.9775 (in increasing order) and they correspond to species
Ornithorhynchus anatinus (Common name: Duck-billed platypus, MLSP: 22.6), Rattus
norvegicus (Common name: Norway rat, MLSP: 3.8), Drosophila melanogaster (Com-
mon name: Fruit fly, MLSP: 0.3) and Gasterosteus aculeatus (Common name: Alaskan
stickleback, MLSP: 8) respectively. In the same figure, the four highest ddG values are:
-0.7211, -0.7373, -0.803 and -0.8441 (in decreasing order) and they correspond to species
Loxodonta africana (Common name: African elephant, MLSP: 65), Latimeria chalumnae
(Common name: Coelacanth, MLSP: 48), Sus scrofa (Common name: Wild boar, MLSP:
27) and Felis catus (Common name: Domestic cat, MLSP: 30) respectively.
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In the values above, we can see that the Duck-billed platypus does not conform to the
general ddG and MLSP trend of the graph. It has a high MLSP despite low protein
stability.
In 5.1b we see that there is a strong positive correlation between mean mean ddG and
MLSP for protein NDUFB6. Meaning that the greater the stability of NDUFB6 for
an organism, the higher the MLSP for it. In the graph, the four lowest ddG values
are: -1.1190, -1.0196, -0.9523 and -0.9363 (in increasing order) and they correspond to
species Ornithorhynchus anatinus (Common name: Duck-billed platypus, MLSP: 22.6),
Anolis carolinensis (Common name: Green anole, MLSP: 7.2), Danio rerio (Common
name: Zebrafish, MLSP: 5.5) and Oryzias latipes (Common name: Japanese medaka,
MLSP: 5) respectively. In the same figure, the four highest ddG values are: -0.5936,
-0.6015, -0.6032 and -0.6215 (in decreasing order) and they correspond to species Tarsius
syrichta (Common name: Philippine tarsier, MLSP: 16), Pan troglodytes (Common name:
Chimpanzee, MLSP: 59.4), Gorilla gorilla (Common name: Gorilla, MLSP: 55.4) and
Felis catus (Common name: Domestic cat, MLSP: 30) respectively.
In the values above, we can see that the lowest ddG value, the Duck-billed platypus with
MLSP: 22.6 does not conform to the general trend. Like ND2, for NDUFB6 too the Duck-
billed platypus has an exceptionally high MLSP despite lowest protein stability among
all species. The highest ddG value, Philippine tarsier with MLSP: 16 does not conform
to the general trend too. Despite the highest protein stability, it has a considerably low
MLSP.
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(a) NDUFA6: ρ=-0.58, p-val=0.00017
(b) NDUFC2: ρ=-0.55, p-val=0.00328
Figure 5.2.: Relationship of mean mean ddG and MLSP with negative correlation
In 5.2a we see that there is a strong negative correlation between mean mean ddG and
MLSP for protein NDUFA6. Meaning that the higher the stability of NDUFA6 for an
organism, the lower the MLSP for it. In the graph, the four lowest ddG values are: -
1.0543, -1.0062, -1.0048 and -1.0035 (in increasing order) and they correspond to species
Macropus eugenii (Common name: Tammar wallaby, MLSP: 15.1), Tursiops truncatus
(Common name: Bottlenosed dolphin, MLSP: 51.6), Tarsius syrichta (Common name:
Philippine tarsier, MLSP: 16) and Equus caballus (Common name: Horse, MLSP: 57)
respectively. In the same figure, the four highest ddG values are: -0.7423, -0.7880, -0.8042
and -0.8181 (in decreasing order) and they correspond to species Danio rerio (Common
name: Zebrafish, MLSP: 5.5), Gasterosteus aculeatus (Common name: Alaskan stickle-
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back, MLSP: 8), Mus musculus (Common name: House mouse, MLSP: 4) and Drosophila
melanogaster (Common name: Fruit fly, MLSP: 0.3) respectively.
In the values above, Tammar wallaby, MLSP: 15.1 and Philippine tarsier, MLSP: 16 do
not follow the trend of the graph; that lower protein stability protein value corresponds
to higher MLSP. These two species have quite low MLSPs in comparison to Bottlenosed
dolphin, MLSP: 51.6 and Horse, MLSP: 57 which have similar protein stability values as
Tammar wallaby and Philippine tarsier.
In 5.2b we see that there is a strong negative correlation between mean mean ddG and
MLSP for protein NDUFC2. Meaning that the higher the stability of NDUFC2 for an
organism, the lower the MLSP for it. In the graph, the four lowest ddG values are:
-1.2343, -1.1961, -1.1822 and 1.1513 (in increasing order) and they correspond to species
Loxodonta africana (Common name: African elephant, MLSP: 65), Procavia capensis
(Common name: Rock hyrax, MLSP: 14.8), Felis catus (Common name: Domestic cat,
MLSP: 30) and Latimeria chalumnae (Common name: Coelacanth, MLSP: 48) respec-
tively. In the same figure, the four highest ddG values are: -0.8956, -0.9154, -0.9285 and
-0.9326 (in decreasing order) and they correspond to species Dipodomys ordii (Common
name: Ord’s kangaroo rat, MLSP: 9.9), Sorex araneus (Common name: Eurasian shrew,
MLSP: 3.2), Cavia porcellus (Common name: Guinea pig, MLSP: 12) and Oryzias latipes
(Common name: Japanese medaka, MLSP: 5) respectively.
In the above values, Rock hyrax, MLSP: 14.8 does not follow the trend of NDUFC2
protein graph. It has a considerably lower MLSP for low stability of NDUFC2 protein
unlike other species for the same protein example: African elephant, MLSP: 65 and
Coelacanth, MLSP: 48 (which also have low stability values).
5.3.2. Analysis for minimum of mean ddG
In minimum of mean ddG value, we take the mean ddG value of all possible mutations at
each site. However we select the minimum value from all the site means as the ddG value
to represent the stability of protein. The minimum ddG value means we are selecting the
most destabilizing mean ddG value for each protein. After that Spearman’s correlation
is found for minimum ddG value and MLSP of all the organisms in which the protein
is found (and for which we have the MLSP). In total 10 proteins with p-value less than
0.05 were found they are given in the table 5.2. Out of the 10 proteins, 4 have a positive
correlation and rest 6 have a negative correlation.
Those proteins with a positive correlation are: NDUFA7, ND2, NDUFB5 and NDUFB6.
The ddG value vs MLSP plots for NDUFA7 and ND2 are given in the figure 5.3 and
discussed in detail below. The plots for the rest of the proteins with positive correlation
are given in figure: B.2 in appendix. The proteins with negative correlation are: NDUFS3,
NDUFA13, NDUFC1, ND4L, NDUFA4 and NDUFB11. The plots for NDUFB11 and
NDUFA13 are given in figure 5.4 and discussed below. The plots for the rest of the
proteins are given by figure B.5 in appendix. The complete table for ρ and p-value for
this method is given by table A.5 in appendix. Significant p-value values (10 proteins)
are marked in blue color.
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(a) NDUFA7: ρ=0.42, p-val=0.01117 (b) ND2: ρ=0.62, p-val=0.0015
Figure 5.3.: Relationship of min mean ddG and MLSP with positive correlation
genes ρ p-val min of mean
NDUFS3 -0.44 0.00755
NDUFA7 0.42 0.01117
NDUFA13 -0.51 0.00445
NDUFC1 -0.45 0.02428
ND2 0.62 0.0015
ND4L -0.41 0.04619
NDUFA4 -0.46 0.00527
NDUFB5 0.36 0.03155
NDUFB6 0.39 0.02421
NDUFB11 -0.62 0.00076
Table 5.2.: Rho and p-value for min of mean ddG
In figure, 5.3b we see that there is a strong positive correlation between min mean ddG and
MLSP for protein ND2. Meaning that the greater the stability of ND2 for an organism,
the higher the MLSP for it. In the graph, the four lowest ddG values are: -3.7537, -3.6605,
-3.6563 and -3.5784 (in increasing order) and they correspond to species Monodelphis do-
mestica (Common name: Shorttailed opossum, MLSP: 5.1), Cavia porcellus (Common
name: Guinea pig, MLSP: 12), Gasterosteus aculeatus (Common name: Alaskan stick-
leback, MLSP: 8) and Drosophila melanogaster (Common name: Fruit fly, MLSP: 0.3)
respectively. In the same figure, the four highest ddG values are: -2.4911, -2.5963, -2.8484
and -2.8784 (in decreasing order) and they correspond to species Loxodonta africana
(Common name: African elephant, MLSP: 65), Meleagris gallopavo (Common name:
Wild turkey, MLSP: 13), Macaca mulatta (Common name: Rhesus monkey, MLSP: 40)
and Latimeria chalumnae (Common name: Coelacanth, MLSP: 48) respectively.
In the values above, we can see that the Guinea pig, MLSP: 12 does not conform to the
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general ddG and MLSP trend of the graph for ND2. It has a considerable high MLSP
corresponding to its low ND2 protein stability. Other species with similar stability value
are: Shorttailed opossum, MLSP: 5.1 and Fruit fly, MLSP: 0.3 which have quite a low
MLSP. Another organism in the above values which doesn’t conform to the graph is Wild
turkey, MLSP: 13. It has a low MLSP even though it has quite a high ND2 protein
stability.
In 5.3a we see that there is a positive correlation between min mean ddG and MLSP for
protein NDUFA7. Meaning that the greater the stability of NDUFA7 for an organism, the
higher the MLSP for it. In the graph, the four lowest ddG values are: -3.0411, -3.0116,
-3.0116 and -2.9984 (in increasing order) and they correspond to species Oryzias latipes
(Common name: Japanese medaka, MLSP: 5), Macropus eugenii (Common name: Tam-
mar wallaby, MLSP: 15), Sarcophilus harrisii (Common name: Tasmanian devil, MLSP:
13) and Oreochromis niloticus (Common name: Nile tilapia, MLSP: 9) respectively. In
the same figure, the four highest ddG values are: -2.1284, -2.1479, -2.1547 and -2.2168
(in decreasing order) and they correspond to species Oryctolagus cuniculus (Common
name: Old World rabbit, MLSP: 9), Ailuropoda melanoleuca (Common name: Giant
panda, MLSP: 36.8), Felis catus (Common name: Domestic cat, MLSP: 30) and Ptero-
pus vampyrus (Common name: Large flying fox, MLSP: 20.9) respectively.
In the values above, we can see that the highest ddG value, Old World rabbit, MLSP: 9
does not conform to the general trend. It has a considerably lower MLSP in comparison
to other species which have similar protein stability for NDUFA7.
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(a) NDUFA13: ρ=-0.51, p-val=0.00445
(b) NDUFB11: ρ=-0.62, p-val=0.00076
Figure 5.4.: Relationship of min mean ddG and MLSP with negative correlation
In 5.4a we see that there is a strong negative correlation between min mean ddG and
MLSP for protein NDUFA13. Meaning that the higher the stability of NDUFA13 for
an organism, the lower the MLSP for it. In the graph, the four lowest ddG values
are: -3.8111, -3.6800, -3.6658 and -3.5695 (in increasing order) and they correspond
to species Ailuropoda melanoleuca (Common name: Giant panda, MLSP: 36.8), Tar-
sius syrichta (Common name: Philippine tarsier, MLSP: 16), Tupaia belangeri (Com-
mon name: Northern tree shrew, MLSP: 11.1) and Loxodonta africana (Common name:
African elephant, MLSP: 65) respectively. In the same figure, the four highest ddG
values are: -2.4574, -2.4789, -2.5495 and -2.5932 (in decreasing order) and they corre-
spond to species Gasterosteus aculeatus (Common name: Alaskan stickleback, MLSP:
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8), Oreochromis niloticus (Common name: Nile tilapia, MLSP: 9), Oryzias latipes (Com-
mon name: Japanese medaka, MLSP: 5) and Monodelphis domestica (Common name:
Short-tailed opossum, MLSP: 5.1) respectively.
In the values above, Philippine tarsier, MLSP: 16 and Northern tree shrew, MLSP: 11.1
do not follow the trend of the graph; that lower protein stability corresponds to higher
MLSP. These two species have quite low MLSPs in comparison to African elephant,
MLSP: 65 and Giant panda, MLSP: 36.8 which have high MLSP corresponding to low
protein stability of NDUFA13.
In 5.4b we see that there is a strong negative correlation between min mean ddG and
MLSP for protein NDUFB11. Meaning that the higher the stability of NDUFB11 for
an organism, the lower the MLSP for it. In the graph, the four lowest ddG values
are: -4.4842, -4.3863, -4.1974 and -4.0326 (in increasing order) and they correspond to
species Macaca mulatta (Common name: Rhesus monkey, MLSP: 40), Monodelphis do-
mestica (Common name: Shorttailed opossum, MLSP: 5.1), Callithrix jacchus (Common
name: White-tufted-ear marmoset, MLSP: 22.8) and Loxodonta africana (Common name:
African elephant, MLSP: 65) respectively. In the same figure, the four highest ddG val-
ues are: -3.2726, -3.3389, -3.4189 and 3.5332 (in decreasing order) and they correspond
to species Sorex araneus (Common name: Eurasian shrew, MLSP: 3.2), Ochotona prin-
ceps (Common name: North American pika, MLSP: 7), Oryzias latipes (Common name:
Japanese medaka, MLSP: 5) and Danio rerio (Common name:Zebrafish, MLSP: 5.5)
respectively.
In the values above, Shorttailed opossum, MLSP: 5.1 does not follow the trend of the
graph; that lower protein stability corresponds to higher MLSP. This organism has quite
a low MLSP in comparison to Rhesus monkey, MLSP: 40, African elephant, MLSP: 65
and even White-tufted-ear marmoset, MLSP: 22.8 which have high MLSP corresponding
to low protein stability (for NDUFB11).
5.3.3. Analysis for ratio of positive mutations and length of
protein
In analysis of ratio of positive mutations, we calculate the ratio of the sum of all positive
mutations in a protein and the length of the protein. Here we have discarded proteins
which are less than two-thirds the average length of all the orthologs. This ratio is then
plotted against the MLSP of all the species where the ortholog is found. The Spearman’s
correlation coefficient and p-value are then calculated. There were 10 proteins with p-
value of less than 0.05 that is 10 proteins are statistically significant. They are given in
table 5.3 along with their ρ and p-value.
The proteins with positive correlation coefficient are: NDUFS8, NDUFB6, NDUFB10
and ND5. The plots for NDUFB6 and ND5 are given in figure 5.5 and discussed below.
The plots for the rest of the proteins with positive correlation are given in figure B.3 in
appendix. The proteins with negative correlation are: NDUFV2, NDUFS3, NDUFS5,
NDUFC2, NDUFA6 and NDUFB5. The plots for NDUFA6 and NDUFB5 are given
in figure 5.6 and discussed below. The plots for the rest of the proteins with negative
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correlation are given in figure B.6 in appendix.The complete table for ρ and p-value for
this method is given by table A.6 in appendix. Significant p-value values (10 proteins)
are marked in blue color.
(a) ND5: ρ= 0.55, p-val= 0.00606 (b) NDUFB6: ρ=0.55, p-val=0.00081
Figure 5.5.: Relationship of ratio and MLSP with positive correlation
genes ρ p-val of ratio
NDUFV2 -0.39 0.0126
NDUFS3 -0.43 0.00921
NDUFS8 0.47 0.00496
NDUFS5 -0.37 0.02665
NDUFA6 -0.59 0.00013
NDUFB5 -0.5 0.00229
NDUFB6 0.55 0.00081
NDUFB10 0.38 0.02112
NDUFC2 -0.52 0.0059
ND5 0.55 0.00606
Table 5.3.: Rho and p-value for ratio of number of positive mutations and length of protein
ddG
In figure, 5.5a we see that there is a strong positive correlation between ratio and MLSP
for protein ND5. Meaning that the greater the stability of ND5 for an organism, the
higher the MLSP for it. In the graph, the four lowest ratio values are: 2.0949, 2.6285,
2.6380 and 2.7129 (in increasing order) and they correspond to species Ornithorhynchus
anatinus (Common name: Duck-billed platypus, MLSP: 22.6), Oryctolagus cuniculus
(Common name: Old World rabbit, MLSP: 9), Sarcophilus harrisii (Common name: Tas-
manian devil, MLSP: 13) and Bos taurus (Common name: Domestic cattle, MLSP: 20)
respectively. In the same figure, the four highest ratio values are: 3.3928, 3.3802, 3.3223
and 3.2604 (in decreasing order) and they correspond to species Latimeria chalumnae
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(Common name: Coelacanth, MLSP: 48), Gallus gallus (Common name: Red junglefowl
(chicken), MLSP: 30), Meleagris gallopavo (Common name: Wild turkey, MLSP: 13) and
Macaca mulatta (Common name: Rhesus monkey, MLSP: 40) respectively.
In the values above, we can see that the Duck-billed platypus, MLSP: 22.6 does not
conform to the general ratio and MLSP trend of the graph. It has a high MLSP despite
low protein stability. Likewise in the higher protein stability values, Wild turkey, MLSP:
13 does not conform to the ratio values of protein ND5 graph since it has a low MLSP
despite a good protein stability. Other species which have comparable protein stability (to
Wild turkey) are: Coelacanth, MLSP: 48, Rhesus monkey, MLSP: 40 and Red junglefowl
(chicken), MLSP: 30. They all have considerably higher MLSPs.
In 5.5b we see that there is a strong positive correlation between ratio and MLSP for
protein NDUFB6. Meaning that the greater the stability of NDUFB6 for an organism,
the higher the MLSP for it. In the graph, the four lowest ratio values are: 2.8595, 3.5984,
3.9375 and 3.9921 (in increasing order) and they correspond to species Ornithorhynchus
anatinus (Common name: Duck-billed platypus, MLSP: 22.6), Anolis carolinensis (Com-
mon name: Green anole, MLSP: 7.2), Danio rerio (Common name: Zebrafish, MLSP:
5.5) and Oryzias latipes (Common name: Japanese medaka, MLSP: 5) respectively. In
the same figure, the four highest ratio values are: 6.0709, 5.9766, 5.9609 and 5.9062
(in decreasing order) and they correspond to species Tarsius syrichta (Common name:
Philippine tarsier, MLSP: 16), Gorilla gorilla (Common name: Gorilla, MLSP: 55.4), Pan
troglodytes (Common name: Chimpanzee, MLSP: 59.4) and Otolemur garnettii (Common
name: Small-eared galago, MLSP: 18.3) respectively.
In the values above, we can see that the lowest ratio value, the Duck-billed platypus
with MLSP: 22.6 does not conform to the general trend. Like ND5, for NDUFB6 too
the Duck-billed platypus has an exceptionally high MLSP despite lowest protein stability
value. The highest ddG value, Philippine tarsier, MLSP: 16 and Small-eared galago,
MLSP: 18.3 do not conform to the general trend for protein NDUFB6. These two species
have quite low MLSPs in comparison to Gorilla, MLSP: 55.4 and Chimpanzee, MLSP:
59.4 which have comparable protein stability for NDUFB6.
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(a) NDUFB5: ρ= -0.5, p-val= 0.00229
(b) NDUFA6: ρ= -0.59, p-val= 0.00013
Figure 5.6.: Relationship of ratio and MLSP with negative correlation
In 5.6a we see that there is a negative correlation between ratio and MLSP for protein
NDUFB5. Meaning that the higher the stability of NDUFB5 for an organism, the lower
the MLSP for it. In the graph, the four lowest ratio values are: 2.7989, 2.8254, 3.0370
and 3.0479 (in increasing order) and they correspond to species Sus scrofa (Common
name: Wild boar, MLSP: 27), Tursiops truncatus (Common name: Bottlenosed dolphin,
MLSP: 51.6), Bos taurus (Common name: Domestic cattle, MLSP: 20) and Oryzias
latipes (Common name: Japanese medaka, MLSP: 5) respectively. In the same figure,
the four highest ratio values are: 4.5323, 4.2103, 4.073 and 4.0332 (in decreasing or-
der) and they correspond to species Drosophila melanogaster (Common name: Fruit fly,
MLSP: 0.3), Monodelphis domestica (Common name: Shorttailed opossum, MLSP: 5.1),
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Callithrix jacchus (Common name: White-tufted-ear marmoset, MLSP: 22.8) and Danio
rerio (Common name: Zebrafish, MLSP: 5.5) respectively.
In the values above, Japanese medaka, MLSP: 5 shows considerable lower MLSP than
its counterparts with similar protein stability value. It does not follow the trend of
the graph; that lower protein stability corresponds to higher MLSP. In the four highest
ratio values, White-tufted-ear marmoset, MLSP: 22.8 shows considerably higher MLSP
for similar protein stability values as its counterparts: Fruit fly, MLSP: 0.3, Shorttailed
opossum, MLSP: 5.1 and Zebrafish, MLSP: 5.5 which have low MLSP corresponding to
high protein stability of NDUFB5.
In 5.6b we see that there is a strong negative correlation between ratio and MLSP for
protein NDUFA6. Meaning that the higher the stability of NDUFA6 for an organism,
the lower the MLSP for it. In the graph, the four lowest ratio values are: 2.9111, 3.2272,
3.2797 and 3.2886 (in increasing order) and they correspond to species Macropus eugenii
(Common name: Tammar wallaby, MLSP: 15.1), Otolemur garnettii (Common name:
Small-eared galago, MLSP: 18.3), Equus caballus (Common name: Horse, MLSP: 57)
and Pteropus vampyrus (Common name: Large flying fox, MLSP: 20.9) respectively. In
the same figure, the four highest ratio values are: 4.9688, 4.7786, 4.6615 and 4.5313 (in
decreasing order) and they correspond to species Danio rerio (Common name: Zebrafish,
MLSP: 5.5), Mus musculus (Common name: House mouse, MLSP: 4), Gasterosteus
aculeatus (Common name: Alaskan stickleback, MLSP: 8) and Oreochromis niloticus
(Common name: Nile tilapia, MLSP: 9) respectively.
In the values above, Tammar wallaby, MLSP: 15.1 and Small-eared galago, MLSP: 18.3
do not follow the trend of the graph; that lower protein stability corresponds to higher
MLSP and higher protein stability corresponds to lower MLSP for NDUFA6.
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There were three methods applied: Mean mean ddG value of protein: where we take the
mean ddG value of each site after all the possible 19 mutations and then for the whole
protein, we take the mean value of all the ddG values per site.
Min mean ddG value of the protein: wherein we take the mean value of ddG per site
(after all the possible 19 mutations) but then we take the min ddG value from all the
site mean values to represent the ddG of the protein. Min value means we take the most
de-stabilizing mean ddg value for each protein.
Ratio method: where we take the ratio of the total positive mutations for a protein and
length of the protein. Sometimes the sign of the mutation is more important than the
actual ddG value (Cheng et al., 2006),that is why this method of comparing the stability
should also work because here we are counting the total positive mutations occurring in
a protein (per site again there will be 19 mutations). So that the length of the protein
does not affect our analysis, we take ratio of positive mutations and length.
Now we compare the stability of proteins and MLSP and the different stability results as
well.
6.1. Compare stability of proteins and MLSP
Mean mean ddG value of protein vs MLSP: For the 45 proteins, we got significant
ρ value for 11 proteins. Out of those, 5 had positive ρ value and 6 proteins had negative
ρ value. Which means that for 5 proteins, the stability of protein increases with increase
in MLSP. For 6 proteins, the stability decreases with increase in species MLSP. Whereas
for 34 proteins, there is no significant relationship between stability and MLSP (as the
p-value for those is > 0.05)
Min mean ddG value of protein vs MLSP: For the 45 proteins, we got significant
ρ value for 10 proteins only. It means that for the remaining 35 proteins, there is no
significant relationship between stability of proteins and MLSP of the species for which
there are orthologs for that protein. For the 10 proteins with significant ρ value, for 4
proteins, there is a positive ρ value and for 6 proteins, there is a negative ρ value. It
means that the stability of the protein increases with MLSP for 4 proteins and decreases
for 6 proteins.
Ratio method of protein vs MLSP: For the 45 proteins, we got significant ρ value for
10 proteins. Out of these 10 proteins, there are 4 proteins with a positive ρ value and 6
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proteins with a negative ρ value. That means for 4 proteins there is a positive correlation
between protein stability and MLSP and for 6 proteins a negative correlation between
protein stability and MLSP. Whereas for the remaining 35 proteins there is no significant
correlation between protein stability and MLSP.
Relationship between stability and MLSP: The compiled result for stability calcu-
lation with the three different methods is given by table 6.1. First we will see all those
proteins which have either a positive ρ value or a negative ρ value by all the three methods.
They are: NDUFB6 (which has a positive ρ value by all three methods) and NDUFS3
(which has a negative ρ value by all the three methods). This is a bit low number than
what I had expected. I was hoping that probably we will get same proteins by the three
methods.
Proteins with significant stability and MLSP ρ
Mean mean Min mean Ratio
Positive ρ
ND2 ND2 ND5
NDUFB4 NDUFB5 NDUFB6
NDUFB6 NDUFB6 NDUFB10
NDUFS8 NDUFA7 NDUFS8
NDUFB10
Negative ρ
NDUFS1 NDUFA13 NDUFV2
NDUFS3 NDUFS3 NDUFS3
NDUFS5 NDUFC1 NDUFS5
NDUFA6 ND4L NDUFA6
NDUFB5 NDUFA4 NDUFB5
NDUFC2 NDUFB11 NDUFC2
Table 6.1.: Proteins with a significant relationship between stability and MLSP
Since we do not have many proteins which are present in all the three methods, we check
proteins which are present in atleast two methods. For positive ρ value we have two
proteins which are common by mean mean method and min mean method: ND2 and
NDUFB6, two proteins by mean mean and ratio methods: NDUFS8 and NDUFB10, one
protein by min mean method and ratio method: NDUFB6. For negative ρ value we have
just one protein by mean mean and min mean method: NDUFS3, one protein by min
mean and ratio method: NDUFS3 and five proteins by mean mean method and ratio
method: NDUFS3, NDUFS5, NDUFA6, NDUFB5 and NDUFC2. This is also shown by
table 6.2.
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Proteins with significant stability and MLSP ρ
Mean mean and Min mean Mean mean and Ratio Min mean and Ratio
Positive ρ ND2 NDUFS8 NDUFB6NDUFB6 NDUFB10
Negative ρ
NDUFS3 NDUFS3 NDUFS3
NDUFS5
NDUFA6
NDUFB5
NDUFC2
Table 6.2.: Proteins common in two methods
We also have one protein which had a positive ρ value by one method and a negative ρ
value by another method. It is NDUFB5 which has a negative ρ value by mean mean
method and ratio method and a positive ρ value by min mean method. For 45 proteins,
there are 19 proteins which have a significant ρ value by any of the three methods (8 pro-
teins with significant positive correlation, 12 with significant negative correlation and 1
protein which has a positive and negative correlation both). Of these 19 proteins, there is
just one protein which has a positive ρ value by one method and a negative ρ value by an-
other method. Proteins with a significant positive correlation: ND2, NDUFB4, NDUFB5,
NDUFB6, NDUFB10, NDUFS8, NDUFA7 and ND5 and proteins with a significant neg-
ative correlation: NDUFB5, NDUFS1, NDUFS3, NDUFS5, NDUFA6, NDUFC2, ND-
UFA13, NDUFC1, ND4L, NDUFA4, NDUFB11 and NDUFV2. All these 19 proteins are
important in the process of ageing as per our analysis, since we got a significant stability
and MLSP correlation for all 19 of them.
6.2. Relation between stability of "core" proteins and
MLSP
The core proteins are: NDUFS1, NDUFS2, NDUFS3, NDUFS8, NDUFS7, NDUFV1,
NDUFV2, ND1, ND2, ND3, ND4, ND4L, ND5 and ND6. The core proteins are the ones
which are catalytically active in the complex. We will see how many out of these proteins
show a significant relationship between stability and MLSP and what sort of relation
there is. First we will look at the above proteins with different stability methods and
then a generalized view:
Mean mean ddG value of "Core" proteins vs MLSP: For NDUFS1, NDUFS3,
NDUFS8 and ND2 there is a significant correlation between MLSP and protein sta-
bility. Thus for 14 "core" proteins, there are 4 proteins with significant relation. Out
of these 4 proteins, NDUFS1 (-0.44; 0.01348) and NDUFS3 (-0.35; 0.04199) have a neg-
ative correlation and NDUFS8 (0.45; 0.00716) and ND2 (0.62; 0.00177) have a positive
correlation.
Min mean ddG value of "Core" proteins vs MLSP: For NDUFS3, ND2 and ND4L
there is a significant correlation between MLSP and protein stability. Thus for 14 "core"
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proteins, there are 3 proteins with significant relation. Out of these 3 proteins, stability
of NDUFS3 (-0.44; 0.00755) and ND4L (-0.41; 0.04619) has a negative correlation with
MLSP and stability of ND2 (0.62; 0.0015) has a positive correlation with MLSP.
Ratio of positive mutations and protein length for "core" proteins vs MLSP: For
NDUFS3, NDUFV2, NDUFS8 and ND5 there is a significant correlation between MLSP
and protein stability. Thus for 14 "core" proteins, there are 4 proteins with a significant
relation between MLSP and stability. Out of these 4 proteins, stability of NDUFS3 (-
0.43; 0.00921) and NDUFV2 (-0.39; 0.0126) has a negative correlation with MLSP and
stability of NDUFS8 (0.47; 0.00496) and ND5 (0.55; 0.00606), has a positive correlation
with MLSP.
Consolidated analysis: All the proteins which have a significant relation between sta-
bility and MLSP by even one method are as follows: NDUFS1, NDUFS3, NDUFS8, ND2,
ND4L, NDUFV2 and ND5. NDUFS3 has a negative ρ value by all the three methods.
ND2 has a positive ρ value by mean mean method and min mean method. NDUFS8 has
a positive ρ value by mean mean method and by ratio method. For "core" proteins there
are no proteins with positive ρ value by all three methods. Also there are no proteins
except NDUFS3 which have a negative ρ value by more than one method. For "core"
proteins, there are also no proteins which have a positive ρ value by one method and
a negative ρ value by another method (that is no contradictory results by the different
methods for "core" proteins). Out of the 14 core proteins, 7 are involved in the process
of ageing as per our analysis. In fact ND2 and ND5 have a high significant positive
correlation for stability and MLSP. Further, out of the 19 candidates which are indicated
to be involved in the process of ageing by our analysis, 7 are "core" proteins that is they
have a catalytic function which is quite a high number.
6.3. Stability difference between proteins encoded by
the mitochondria and nuclear encoded proteins
There are total 7 mitochondrial proteins and 38 nuclear proteins.
Mean mean method: In mean mean method, there are 11 proteins with a significant
relationship between MLSP and protein stability. Out of these 11, 1 protein is encoded
by mtDNA (ND2). So that is 1 protein out of 7 and for nuclear encoded proteins, 10 out
of 38. ND2 has positive ρ value.
Min mean method: In min mean method, there are 10 proteins with a significant
relationship between MLSP and protein stability. Out of these 10, 2 proteins are encoded
by mitochondria (ND2 and ND4L). So that is 2 proteins out of 7 and for nuclear encoded
proteins, 8 out of 38. ND2 has positive ρ value and ND4L has negative ρ value.
Ratio method: In ratio method, there are 10 proteins with a significant relationship
between MLSP and protein stability. Out of these 10, 1 protein is encoded by mitochon-
dria (ND5). So that is 1 protein out of 7 and for nuclear encoded proteins, 9 out of 38.
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ND2 has positive ρ value.
If we take all proteins for which we got a significant ρ value, among mitochondrially
encoded proteins, we have: ND2, ND4L and ND5 (which is 3 out of 7). Out of these
3, 2 proteins have a positive MLSP and stability correlation. Remaining 16 are nuclear
encoded proteins out of 38. Out of those 16, 6 proteins have a significant positive correla-
tion of protein stability and MLSP where as 11 have a significant negative correlation of
protein stability and MLSP. Out of the 19 statistically significant proteins of our analysis,
only 3 are encoded by the mitochondria (mitochondria encodes a total of 7 proteins of
complex I). Thus Mitochondrial proteins of complex I which are involved in the process
of ageing by our analysis are: ND2, ND4L and ND5.
6.4. Future Research
The main aim of this study was to find proteins from Complex I which might have a role
in the process of ageing. We have found those proteins however there is much scope for
further research.
We have found 8 proteins which have a significant positive correlation between sta-
bility and MLSP. They are: ND2, ND5, NDUFB4, NDUFB5, NDUFB6, NDUFB10,
NDUFS8 and NDUFA7. There are 12 proteins which show a significant negative corre-
lation between MLSP and stability. They are: NDUFS1, NDUFS3, NDUFS5, NDUFA6,
NDUFB5, NDUFC2, NDUFA13, NDUFC1, ND4L, NDUFA4, NDUFB11 and NDUFV2.
Of the 8 proteins that demonstrate a significant positive correlation, ND2, ND5 and
NDUFS8 have a catalytic function (in humans). Likewise for the 12 proteins with a sig-
nificant negative correlation, NDUFS1, NDUFS3, ND4L and NDUFV2 have a catalytic
function (in humans). They form part of what is known as the catalytic "core". The rest
of the 5 out of 8 and 8 out of 12 proteins however have no catalytic function. Thus we
can say that some catalytic proteins also demonstrate MLSP and stability correlation.
However not all the proteins that demonstrate a correlation of stability with MLSP be-
long to the catalytic category. Further detailed study of functional information of all the
statistically significant proteins could be quite significant in age related studies regarding
Complex I. Thus a detailed study of the functions of these 19 proteins can be made. A
comprehensive study could also me made regarding the involvement of these 19 significant
proteins in various diseases we have discussed here.
Further analysing our statistically significant proteins based on their sub-cellular loca-
tion:
• ND2: Mitochondrial membrane; Multi-pass
• NDUFB4: Mitochondrial inner membrane; Single pass
• NDUFB5: Mitochondrial inner membrane; Single pass
• NDUFB6: Mitochondrial inner membrane; Single pass
• NDUFB10: Peripheral
• ND5: Mitochondrial inner membrane; Multi-pass
• NDUFS1: Inner membrane (not mentioned whether single-pass or multi-pass)
• NDUFS5: Inner membrane; Single pass
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• NDUFC2: Mitochondrial inner membrane: Single pass
• ND4L: Mitochondrial membrane; Multi-pass
• NDUFA4: Peripheral
Sub-cellular location of NDUFS8, NDUFA7, NDUFS3, NDUFA6, NDUFA13, NDUFC1,
NDUFB11 and NDUFV2 is not available from information downloaded from entrez. As
we can see from the above listing, most proteins which have a statistically significant
relationship between stability and MLSP are in mitochondrial inner membrane. How-
ever sub-cellular location information of 8 out of 19 proteins is not readily available. A
better analysis can be made if we explore more about the sub-cellular location of the 19
proteins.
The results of our study could have been more conclusive regarding targeting certain
species for further age related studies if we had same organisms across all the 45 proteins.
In our present analysis we have different species (for which orthologs were available)
for each protein. If we had orthologs for all the species across all the 45 proteins, we
could have made a good comparative analysis of anomalous behaviour of species. For
example in the results chapter where we have discussed about some of the graphs, we
observed that some species behave anomalously: like the duck-billed platypus which
showed a high MLSP despite having the lowest stability among all organisms for ND2,
ND5 and NDUFB6 proteins (though all these 3 proteins had a positive MLSP and stability
correlation). This kind of analysis would have been easier if we had sequences for all the
species. It would also have given us some species with an anomalous behaviour as subjects
for further study.
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The main aim of our study was to find proteins in Complex I which emulate the MLSP
and oxidative damage correlation. We have found eight proteins which have a signifi-
cant positive correlation between stability and MLSP. Of these eight proteins, NDUFB6
demonstrates a significant positive correlation by all the three methods that we had ap-
plied. ND2, NDUFB10 and NDUFS8 demonstrate a significant positive correlation by
two methods. Thus these eight proteins and specially the four proteins (which demon-
strate a significant correlation by more than one method) can be subjects of further
analysis in studies related to the process of ageing because they show a significant pos-
itive correlation between stability and MLSP much like the mitochondrial free radical
theory of ageing.
Apart from these proteins, there are twelve proteins which show a significant negative
correlation between MLSP and stability. Out of these proteins NDUFS3 demonstrates a
significant negative correlation by all the three methods applied and proteins NDUFS5,
NDUFA6, NDUFB5 and NDUFC2 demonstrate a significant negative correlation by two
methods. Even these twelve proteins and specially the five proteins (which demonstrate
a significant correlation by more than one method) can be good candidates for further
analysis as they show a significant correlation between MLSP and stability. Further, out
of our nineteen statistically significant proteins, seven are involved in catalytic activity
and three of the nineteen proteins are encoded by mtDNA.
The nineteen proteins, out of the forty five Complex I proteins, which demonstrate a
significant metabolic activity and MLSP correlation are: ND2, ND5, NDUFB4, NDUFB5,
NDUFB6, NDUFB10, NDUFS8, NDUFA7, NDUFS1, NDUFS3, NDUFS5, NDUFA6,
NDUFC2, NDUFA13, NDUFC1, ND4L, NDUFA4, NDUFB11 and NDUFV2. Out of
these proteins, NDUFS1, NDUFS3, NDUFS8, ND2, ND4L, NDUFV2 and ND5 proteins
have a catalytic function and ND2, ND5 and ND4L are encoded by the mitochondria.
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A. Appendix
Species Scientific Name MLSP in years
Roundworm Caenorhabditis elegans 0.16
Fruit fly Drosophila melanogaster 0.3
Eurasian shrew Sorex araneus 3.2
Norway rat Rattus norvegicus 3.8
House mouse Mus musculus 4
Japanese medaka Oryzias latipes 5
Shorttailed opossum Monodelphis domestica 5.1
Zebra danio or zebrafish Danio rerio 5.5
North American pika Ochotona princeps 7
Green anole Anolis carolinensis 7.2
Alaskan stickleback Gasterosteus aculeatus 8
Sea lamprey Petromyzon marinus 9
Nile tilapia Oreochromis niloticus 9
Old World rabbit Oryctolagus cuniculus 9
Ord’s kangaroo rat Dipodomys ordii 9.9
Northern tree shrew Tupaia belangeri 11.1
Western European hedgehog Erinaceus europaeus 11.7
Guinea pig Cavia porcellus 12
Zebra finch Taeniopygia guttata 12
Tasmanian devil Sarcophilus harrisii 13
Wild turkey Meleagris gallopavo 13
Table A.1.: Maximum Lifespan of species
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Species Scientific Name MLSP in years
Tammar wallaby Macropus eugenii 15.1
Philippine tarsier Tarsius syrichta 16
Gray mouse lemur Microcebus murinus 18.2
Small-eared galago Otolemur garnettii 18.3
Lesser hedgehog tenrec Echinops telfairi 19
Domestic cattle Bos taurus 20
Large flying fox Pteropus vampyrus 20.9
Common long-nosed armadillo Dasypus novemcinctus 22.3
Duck-billed platypus Ornithorhynchus anatinus 22.6
White-tufted-ear marmoset Callithrix jacchus 22.8
Wild boar Sus scrofa 27
Domestic cat Felis catus 30
Red junglefowl (chicken) Gallus gallus 30
Little brown bat Myotis lucifugus 34
Giant panda Ailuropoda melanoleuca 36.8
Rhesus monkey Macaca mulatta 40
Hoffmann’s two-toed sloth Choloepus hoffmanni 41
Coelacanth Latimeria chalumnae 48
Bottlenosed dolphin Tursiops truncatus 51.6
Gorilla Gorilla gorilla 55.4
Horse Equus caballus 57
Chimpanzee Pan troglodytes 59.4
African elephant Loxodonta africana 65
Human Homo sapiens 122.5
Table A.2.: Maximum Lifespan of species
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Approved Symbol Location
MT-ND1 mitochondria
MT-ND2 mitochondria
MT-ND3 mitochondria
MT-ND4 mitochondria
MT-ND4L mitochondria
MT-ND5 mitochondria
MT-ND6 mitochondria
NDUFA1 Xq24
NDUFA2 5q31.2
NDUFA3 19q13.42
NDUFA4 7p21.3
NDUFA5 7q31.33
NDUFA6 22q13.2
NDUFA7 19p13.2
NDUFA8 9q33.2
NDUFA9 12p13.3
NDUFA10 2q37.3
NDUFA11 19p13.3
NDUFA12 12q22
NDUFA13 19p13.11
NDUFAB1 16p12.3
NDUFB1 14q31.3
NDUFB2 7q34
NDUFB3 2q33.1
NDUFB4 3q13.33
NDUFB5 3q27.1
NDUFB6 9p13.2
NDUFB7 19p13.12
NDUFB8 10q24.31
NDUFB9 8q24.13
NDUFB10 16p13.3
NDUFB11 Xp11.3
NDUFC1 4q31.1
NDUFC2 11q14.1
NDUFS1 2q33-q34
NDUFS2 1q23.3
NDUFS3 11p11.11
NDUFS4 5q11.1
NDUFS5 1p34.2-p33
NDUFS6 5p15.33
NDUFS7 19p13
NDUFS8 11q13.2
NDUFV1 11q13
NDUFV2 18p11.22
NDUFV3 21q22.3
Table A.3.: Complex I genes and their genomic locations. Source: (EMBL-EBI, 2014)
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Number Gene Name ρ p-val
1 NDUFV1 -0.19 0.26969
2 NDUFV2 -0.23 0.15807
3 NDUFV3 0.01 0.97506
4 NDUFS1 -0.44 0.01348
5 NDUFS2 0.06 0.77122
6 NDUFS3 -0.35 0.04199
7 NDUFS4 0.09 0.58194
8 NDUFS6 0.37 0.05524
9 NDUFS7 -0.32 0.12507
10 NDUFS8 0.45 0.00716
11 NDUFA2 -0.23 0.16541
12 NDUFA5 -0.13 0.50665
13 NDUFA7 0.33 0.05195
14 NDUFA12 0 0.98973
15 NDUFA13 0.02 0.90309
16 NDUFS5 -0.37 0.02835
17 NDUFA1 -0.29 0.08147
18 NDUFA3 0.1 0.61198
19 NDUFA6 -0.58 0.00017
20 NDUFA8 0.16 0.36692
21 NDUFA9 -0.07 0.68399
22 NDUFA10 0.11 0.54629
23 NDUFA11 -0.11 0.60857
24 ND6 0.07 0.74342
25 NDUFC1 0.01 0.95746
26 ND1 0.28 0.22448
27 ND2 0.62 0.00177
28 ND3 0.21 0.3417
29 ND4L -0.28 0.18767
30 NDUFA4 -0.16 0.36545
31 NDUFAB1 -0.09 0.60363
32 NDUFB4 0.34 0.04872
33 NDUFB1 -0.1 0.66821
34 NDUFB2 0.19 0.26325
35 NDUFB3 0.32 0.05459
36 NDUFB5 -0.46 0.00569
37 NDUFB6 0.52 0.00172
38 NDUFB7 -0.01 0.95707
39 NDUFB8 -0.03 0.86997
40 NDUFB9 0.08 0.6615
41 NDUFB10 0.45 0.00543
42 NDUFB11 -0.24 0.24419
43 NDUFC2 -0.55 0.00328
44 ND4 0.42 0.05948
45 ND5 0.39 0.06244
Table A.4.: MLSP vs Mean of mean ddG value per site mutation
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Number Gene Name ρ p-val
1 NDUFV1 -0.3 0.0738
2 NDUFV2 0.09 0.58147
3 NDUFV3 -0.16 0.43431
4 NDUFS1 -0.21 0.24973
5 NDUFS2 -0.08 0.66985
6 NDUFS3 -0.44 0.00755
7 NDUFS4 0.27 0.11658
8 NDUFS6 0.13 0.51406
9 NDUFS7 -0.14 0.52387
10 NDUFS8 -0.28 0.10901
11 NDUFA2 0.04 0.79358
12 NDUFA5 0.29 0.13151
13 NDUFA7 0.42 0.01117
14 NDUFA12 -0.21 0.23795
15 NDUFA13 -0.51 0.00445
16 NDUFS5 -0.19 0.26824
17 NDUFA1 -0.05 0.79211
18 NDUFA3 -0.18 0.34194
19 NDUFA6 -0.13 0.45419
20 NDUFA8 0.27 0.12367
21 NDUFA9 -0.14 0.45271
22 NDUFA10 -0.21 0.25896
23 NDUFA11 0.01 0.95041
24 ND6 -0.21 0.3383
25 NDUFC1 -0.45 0.02428
26 ND1 0.15 0.5204
27 ND2 0.62 0.0015
28 ND3 0.1 0.63625
29 ND4L -0.41 0.04619
30 NDUFA4 -0.46 0.00527
31 NDUFAB1 -0.21 0.24908
32 NDUFB4 0.26 0.13046
33 NDUFB1 -0.18 0.4119
34 NDUFB2 0.12 0.49161
35 NDUFB3 -0.06 0.74779
36 NDUFB5 0.36 0.03155
37 NDUFB6 0.39 0.02421
38 NDUFB7 0.28 0.1343
39 NDUFB8 0.19 0.26348
40 NDUFB9 -0.01 0.965
41 NDUFB10 0.28 0.09034
42 NDUFB11 -0.62 0.00076
43 NDUFC2 -0.15 0.47399
44 ND4 -0.05 0.81829
45 ND5 0.03 0.90433
Table A.5.: MLSP vs Min of mean ddG value per site of mutation
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Number Gene Name ρ p-val
1 NDUFV1 -0.15 0.39768
2 NDUFV2 -0.39 0.0126
3 NDUFV3 -0.23 0.26097
4 NDUFS1 -0.24 0.18717
5 NDUFS2 0.01 0.94325
6 NDUFS3 -0.43 0.00921
7 NDUFS4 0.11 0.52193
8 NDUFS6 0.07 0.72998
9 NDUFS7 -0.23 0.27846
10 NDUFS8 0.47 0.00496
11 NDUFA2 -0.24 0.15162
12 NDUFA5 -0.21 0.26497
13 NDUFA7 0.17 0.31104
14 NDUFA12 -0.05 0.79676
15 NDUFA13 0.16 0.39943
16 NDUFS5 -0.37 0.02665
17 NDUFA1 -0.25 0.13921
18 NDUFA3 0.19 0.33017
19 NDUFA6 -0.59 0.00013
20 NDUFA8 -0.02 0.92719
21 NDUFA9 0 0.99444
22 NDUFA10 0.18 0.33304
23 NDUFA11 -0.17 0.39403
24 ND6 0.24 0.27642
25 NDUFC1 -0.15 0.45984
26 ND1 0.31 0.16592
27 ND2 0.32 0.13356
28 ND3 0.21 0.34441
29 ND4L -0.24 0.25744
30 NDUFA4 -0.06 0.73037
31 NDUFAB1 0.05 0.76461
32 NDUFB4 0.29 0.08964
33 NDUFB1 0.08 0.71669
34 NDUFB2 0.14 0.40369
35 NDUFB3 0.16 0.33729
36 NDUFB5 -0.5 0.00229
37 NDUFB6 0.55 0.00081
38 NDUFB7 -0.14 0.46803
39 NDUFB8 0 0.99389
40 NDUFB9 0.18 0.32841
41 NDUFB10 0.38 0.02112
42 NDUFB11 0.04 0.84633
43 NDUFC2 -0.52 0.0059
44 ND4 0.31 0.17153
45 ND5 0.55 0.00606
Table A.6.: MLSP vs Ratio of all positive mutations and protein length
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Genes Sub-cellular location
NDUFV1 Mitochondrion inner membrane; Peripheral
NDUFV3 Mitochondrion inner membrane; Peripheral
NDUFS1 Mitochondrion inner membrane
NDUFS2 Mitochondrion inner membrane; Peripheral
NDUFS4 Mitochondrion inner membrane; Peripheral
NDUFS7 Mitochondrion
NDUFS8 Mitochondrion (Probable)
NDUFA2 Mitochondrion inner membrane; Peripheral
NDUFA12 Mitochondrion inner membrane; Peripheral
NDUFS5 Mitochondrion. Mitochondrion inner membrane;
NDUFA1 Mitochondrion inner membrane; Single-pass
NDUFA3 Mitochondrion inner membrane; Single-pass
NDUFA8 Mitochondrion. Mitochondrion intermembrane
NDUFA9 Mitochondrion matrix.
NDUFA10 Mitochondrion matrix
NDUFA11 Mitochondrion inner membrane; Multi-pass
MT-ND6 Mitochondrion membrane; Multi-pass membrane
MT-ND1 Mitochondrion membrane; Multi-pass membrane
MT-ND2 Mitochondrion membrane; Multi-pass membrane
MT-ND3 Mitochondrion membrane; Multi-pass membrane
MT-ND4L Mitochondrion membrane; Multi-pass membrane
NDUFA4 Mitochondrion inner membrane; Peripheral
NDUFB4 Mitochondrion inner membrane; Single-pass
NDUFB2 Mitochondrion inner membrane; Peripheral
NDUFB3 Mitochondrion inner membrane; Single-pass
NDUFB5 Mitochondrion inner membrane; Single-pass
NDUFB6 Mitochondrion inner membrane; Single-pass
NDUFB9 Mitochondrion inner membrane; Peripheral
NDUFB10 Mitochondrion inner membrane; Peripheral
NDUFB11 Mitochondrion inner membrane; Single-pass
NDUFC2 Mitochondrion inner membrane; Single-pass
MT-ND4 Mitochondrion membrane; Multi-pass membrane
MT-ND5 Mitochondrion inner membrane; Multi-pass
Table A.7.: The sub-cellular location of the proteins
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(a) NDUFB4: ρ=0.34, p-val=0.04872
(b) NDUFS8: ρ=0.45, p-val=0.00716 (c) NDUFB10: ρ=0.45, p-val=0.00543
Figure B.1.: Relationship of mean mean ddG and MLSP with positive correlation
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(a) NDUFB5: ρ=0.36, p-val=0.03155 (b) NDUFB6: ρ=0.39, p-val=0.02421
Figure B.2.: Relationship of min mean ddG and MLSP with positive correlation
(a) NDUFB10: ρ=0.38, p-val= 0.02112 (b) NDUFS8: ρ= 0.47, p-val=0.00496
Figure B.3.: Relationship of ratio and MLSP with positive correlation
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(a) NDUFS1: ρ=-0.44, p-val=0.01348 (b) NDUFS3: ρ=-0.35, p-val=0.04199
(c) NDUFS5: ρ=-0.37, p-val=0.02835
(d) NDUFB5: ρ=-0.46, p-val=0.00569
Figure B.4.: Relationship of mean mean ddG and MLSP with negative correlation
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(a) NDUFS3: ρ=-0.44, p-val=0.00755 (b) NDUFC1: ρ=-0.45, p-val=0.02428
(c) ND4L: ρ=-0.41, p-val=0.04619
(d) NDUFA4: ρ=-0.46, p-val=0.00527
Figure B.5.: Relationship of min mean ddG and MLSP with negative correlation
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(a) NDUFV2: ρ= -0.39, p-val= 0.0126 (b) NDUFS3: ρ= -0.43, p-val= 0.00921
(c) NDUFS5: ρ= -0.37, p-val= 0.02665 (d) NDUFC2: ρ= -0.52, p-val= 0.0059
Figure B.6.: Relationship of ratio and MLSP with negative correlation
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